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Map 1: States in which Human Rights Watch conducted field research 
on palliative care 
 
© 2009 John Emerson 
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 Overview 
 
In late 2007 Muzaffar Iqbal, a 65-year-old rickshaw driver from a small village in Andhra 
Pradesh, first noticed a growth near his right armpit. When the growth became painful, he 
went to a local doctor who gave him a basic painkiller and suggested that he undergo a 
biopsy. Iqbal learned that he had lung cancer. 
 
As Iqbal sought and later underwent treatment, he developed a piercing chest pain that 
became excruciating. Though he repeatedly informed his doctors, he found them 
unresponsive. In an interview with Human Rights Watch, he said, “They sent me here, there, 
everywhere, but nobody ever asked me if I had pain.” As the pain got worse and no 
treatment was forthcoming from his healthcare providers, Iqbal unsuccessfully tried to self-
medicate with paracetamol from a local pharmacy. Ultimately, his pain got so bad that he 
wished that “God would take me away....”1 
 
Raj Ramachandran, a rubber-tapper from a small village in Kerala, had a similar experience. 
Ramachandran developed a swelling in his neck in 2006, which turned out to be cancer of 
the parotid gland. After initial surgery seemed successful, Ramachandran had a recurrence 
in March 2007. Shortly after, he developed severe pain. Ramachandran’s doctors would give 
him some medications when he discussed his pain with them but, he said, the paracetamol 
his wife bought at the local pharmacy brought more relief than the medications he received 
from his doctors. His pain became so severe that he could no longer sleep, could not lie 
down, and wanted to end his life.2  
 
Stories of suffering like those of Muzaffar Iqbal and Raj Ramachandran are all too common in 
India. Although enormous problems exist with availability and accessibility of health 
services at all levels of care in India—due to limited resources and weak public healthcare 
services—the suffering of patients like Iqbal and Ramachandran can be easily and cheaply 
prevented. Morphine, the key medication for treating moderate to severe pain, is 
inexpensive, highly effective, and generally not complicated to administer. 
 
Palliative care—a field of medicine that does not seek to cure but to improve the quality of 
life of patients with life-limiting illnesses3—can be delivered at limited cost both in the 
                                                          
1 Human Rights Watch interview with Muzaffar Iqbal (pseudonym), Hyderabad, India, March 28, 2008. 
2 Human Rights Watch interview with Raj Ramachandran (pseudonym), Kerala, March 22, 2008. 
3 While palliative care is often associated with terminal illness, it can benefit patients with a much broader group of illnesses 
or health conditions. Palliative care advocates use the term “life-limiting” illness or health condition to delineate the group of 
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community through home-based care and at healthcare centers. It includes treatment of 
pain and of other problems, whether physical, psychosocial, or spiritual. Indeed, after 
considerable suffering, both Iqbal and Ramachandran ended up being cared for by palliative 
care programs—one offered by a cancer hospital in Andhra Pradesh, the other by a 
nongovernmental organization (NGO) in Kerala—where they received proper treatment for 
their pain, as well as psychological and spiritual support. 
 
In this respect, Iqbal and Ramachandran are the exceptions. Leading palliative care experts 
in India estimate that more than one million people in India suffer from moderate to severe 
pain every year due to advanced cancer. That number rises considerably once people with 
non-advanced cancer, HIV and AIDS, and a variety of other progressive, incurable or 
otherwise life-limiting health conditions are included. These experts believe that more than 
seven million people may suffer from pain and other symptoms due to such illnesses and 
conditions annually. Only a small fraction of these people have access to adequate palliative 
health services. In 2008 India used an amount of morphine that was sufficient to adequately 
treat during that year only about 40,000 patients suffering from moderate to severe pain due 
to advanced cancer, about 4 percent of those requiring it. 
 
Most patients with advanced cancer are simply sent home when curative treatment 
options—or money to pay for such treatment—are exhausted. Abandoned by the healthcare 
system at arguably the most vulnerable time of their lives, they face pain, fear, and anguish 
without professional support, and die in the confines of their homes. Even most large cancer 
hospitals in India, including 18 of 29 government-designated lead cancer centers, do not 
have personnel trained to administer palliative care or morphine and other strong pain 
medications. This is particularly startling given that about 70 percent of the patients seen at 
these hospitals are at such an advanced stage of cancer upon arrival that they are beyond 
cure; palliative care and pain management is the only benefit they may still receive. 
 
Similarly, people with HIV and AIDS, paraplegics, patients with advanced renal disease, or 
elderly people who suffer from physical or psychological pain and require palliative care 
services, are unable to access them in most parts of India. Like most cancer hospitals, the 
vast majority of community care centers for people living with HIV, antiretroviral clinics, or 
secondary and primary health centers do not offer palliative care as they do not have the 
necessary medications, including morphine, or trained healthcare workers. 
                                                                                                                                                                             
patients who would benefit from the services provided by palliative care, including symptom control, pain treatment, 
psychosocial and spiritual support and others. A life-limiting illness or health condition is a chronic condition that limits or 
has the potential to limit the patient’s ability to lead a normal life and includes, among others, cancer, HIV/AIDS, dementia, 
heart, renal, and liver disease, and permanent serious injury. 
Unbearable Pain     4 
The World Health Organization (WHO) has recognized palliative care as an integral and 
essential part of comprehensive care for cancer, HIV, and other health conditions. With 
respect to cancer, for example, it has noted that, despite improvements in survival rates, 
 
... the majority of cancer patients will need palliative care sooner or later. In 
developing countries, the proportion requiring palliative care is at least 80 
percent. Worldwide, most cancers are diagnosed when already advanced 
and incurable ... [For these patients] the only realistic treatment option is 
pain relief and palliative care.4 
 
The WHO has urged countries to take action in three areas—policy making, education, and 
drug availability—that it sees as fundamental for the development of palliative care and pain 
management services. It has observed that these measures cost little but can have 
significant effect. In India major challenges exist in all three areas. 
 
Government authorities in India, both at the central and state level, have done too little to 
make sure that palliative care and pain management services are available, or to facilitate 
their provision by the private sector or nongovernmental organizations. In fact, many state 
governments continue to enact complex narcotics regulations that actively impede the 
availability of morphine, despite a key recommendation by the central government to 
simplify them. 
 
Policy. The World Health Organization has recommended that countries establish a national 
palliative care policy or program. In India, however, a national policy or program does not 
exist, even though such policies exist for various other illnesses and conditions. The 
government has invested considerable resources in strengthening its cancer care system, 
but almost none of these funds have been allocated to palliative care provision, despite the 
fact that the majority of cancer patients require such services and the national cancer control 
program makes an explicit reference to palliative care. India’s national AIDS control program 
makes reference to palliative care but, to date, no palliative care services for people living 
with HIV and AIDS have been developed. No state palliative care policies exist in any of 
India’s states and territories, with the exception of Kerala. 
 
Education. The World Health Organization also recommends that countries ensure adequate 
instruction of healthcare workers on palliative care and pain treatment. Yet, in India, official 
                                                          
4 World Health Organization (WHO), “National Cancer Control Programmes: Policies and Managerial Guidelines, second 
edition,” 2002, pp. 86-87. 
      5       Human Rights Watch | October 2009 
curricula for undergraduate and postgraduate medical studies do not provide for any 
specific education on palliative care and pain management. According to leading palliative 
care doctors, out of more than 300 medical colleges, only five in the entire country have 
integrated some instruction on palliative care into subjects of the official curriculum. While a 
few teaching hospitals offer rotations in palliative care units for postgraduate students in 
oncology or anesthesiology, most of these hospitals simply lack such units. As a result, the 
vast majority of medical doctors in India are unfamiliar with even the most basic tenets of 
palliative care or pain management. 
 
Drug availability. Finally, the World Health Organization recommends that countries 
establish a rational drug policy that ensures availability and accessibility of essential 
medicines, including morphine. Because opioids are controlled substances globally—and 
are thus not freely available on the market—ensuring their availability for medical purposes 
is more complicated than it is for most other drugs. States have an obligation under 
international law to both ensure the availability of opioids for medical purposes and take 
steps to prevent their misuse. 
 
While the Indian government, to its credit, recommended in 1998 that states adopt narcotics 
regulations that create a balance between these two requirements (the Department of 
Revenue’s “model rule”), two-thirds of India’s states have failed to do so and maintain 
outdated regulations for opioid medications that, in the words of India’s own national 
Department of Revenue, deny “easy availability of morphine to even terminally ill cancer 
patients” and have caused “undue sufferings and harassment” because they are “often too 
strict and cumbersome.” Because of these regulations many hospitals and pharmacies do 
not want to commit the amount of time it takes to go through the bureaucratic steps required 
to obtain morphine, and thus simply do not stock it. Others find that the bureaucratic 
intricacies frequently result in shortages and delays as bottlenecks and red tape interrupt 
the supply chain. 
 
Policy, education, and drug availability barriers have created a vicious cycle: Because pain 
treatment and palliative care are not priorities for the government, healthcare workers do not 
receive the necessary training to provide these services. This leads to widespread under-
treatment, including of pain, and to low demand for morphine. At the same time, complex 
procurement regulations discourage pharmacies and hospitals from stocking and healthcare 
workers from prescribing it, again resulting in low demand. This, in turn, reinforces the low 
priority given to pain management and palliative care. 
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Under the International Covenant on Economic, Social and Cultural Rights, the Indian 
government has an obligation to take steps “to the maximum of its available resources” to 
achieve progressively all the rights in that covenant, including the right to health. Therefore 
the government should ensure that patients who require palliative care and pain treatment 
can get access to these health services. In particular, it should formulate a plan for the 
development and implementation of these services, ensure the availability and accessibility 
of morphine and other medications that the World Health Organization considers essential, 
and ensure that healthcare providers receive training in palliative care. The failure of the 
Indian government to do so violates the right to health. 
 
The right to health also requires a rational and equitable distribution of resources for 
healthcare services, based on the health needs of the population. The Indian government, 
however, while investing considerable resources into cancer and HIV services, has failed to 
make effective provision of palliative care, even though the need for such services is 
extremely high. 
 
Under the prohibition of torture and ill-treatment, the Indian government has a positive 
obligation to take measures to protect people under its jurisdiction from inhuman or 
degrading treatment such as unnecessarily suffering from extreme pain. As the UN special 
rapporteur on torture and other cruel, inhuman or degrading treatment or punishment has 
noted, “failure of governments to take reasonable measures to ensure accessibility of pain 
treatment ... raises questions whether they have adequately discharged this obligation.” The 
fact that many of the government-designated regional cancer centers in India, which treat 
very large numbers of patients who require palliative care, do not offer it, do not stock 
morphine, and do not have healthcare workers on staff who have been trained in palliative 
care, strongly suggests that the Indian government has not taken any such reasonable 
measures. It may thus be liable under the prohibition of torture and cruel, inhuman, or 
degrading treatment for the unnecessary suffering of patients with severe pain and other 
symptoms at such regional cancer centers. 
 
In order to end this unnecessary suffering, the Indian government will need to recognize the 
urgency of the problem and take proactive steps. Faced with similar situations, several other 
countries in Asia and elsewhere have organized meetings at which all relevant parties—
health authorities, drug regulators, palliative care groups, and others—have been brought 
together to develop a comprehensive strategy for developing palliative care services and 
ensuring access to pain medications. In several countries, these inter-agency meetings have 
allowed a coordinated and comprehensive approach to removing the various barriers, 
whether regulatory, educational, or otherwise, that impede that process.  
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While developing palliative care services and integrating them into the healthcare system is 
a significant challenge, India has a considerable advantage compared to most other 
countries in the region. The southern state of Kerala is home to one of the most effective 
community-based palliative care networks in the world. Outside Kerala there are a number of 
strong palliative care programs, based both in the community and at healthcare institutions. 
Nongovernmental organizations, such as the Indian Association of Palliative Care, the 
Institute of Palliative Medicine, and Pallium India, among others, have developed palliative 
care courses for healthcare workers and have extensive experience providing such training. 
Finally, the Department of Revenue’s model rule for simplifying access to morphine has 
already been successfully implemented in several states. The central and state governments 
urgently need to draw on these experiences to develop effective plans of action that 
guarantee access to palliative care and pain treatment. 
 
* * * 
 
This report focuses specifically on the poor availability of palliative care services in India. 
Human Rights Watch, however, fully recognizes the enormous problems that exist with poor 
availability and accessibility of health services at all levels of care in India, as a result of 
resource problems, inadequate infrastructure, shortages of medicines, and weak public 
healthcare services. The fact that this report focuses on a specific area of healthcare does 
not suggest that government authorities in India do not have an obligation under 
international human rights law to take reasonable steps to address problems in other parts 
of the healthcare system. 
 
Key Recommendations 
The Indian government and state governments should, in consultation with stakeholders, 
immediately develop action plans to ensure access to palliative care and pain management 
nationwide. In particular, they should: 
 
• Develop national and state palliative care policies and strategies, and identify 
specific benchmarks and timelines for implementation. These should provide for 
both the establishment of institution-based and community-based palliative care. 
• Integrate meaningful palliative care strategies into national cancer and HIV/AIDS 
control programs. 
• Mandate basic instruction on palliative care into the curriculum for all medical 
colleges. 
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• Adopt and operationalize throughout the country the model rule on morphine 
availability and remove any other regulatory barriers that arbitrarily impede access to 
opioid medications, while ensuring adequate control to prevent their misuse. 
• Expand palliative care services to all regional cancer centers and adopt a clear plan 
of action for the establishment of such services at other cancer hospitals. 
• Ensure that oral morphine is included in essential medicines lists, and that 
medications included are available in practice. 
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Methodology 
 
This report is based on research conducted over a one-year period, including field visits to 
India in March-April 2008 and February 2009. Our field research was conducted primarily in 
the states of Andhra Pradesh, Kerala, Rajasthan, and West Bengal. We chose these states 
because of their different levels of palliative care development and their geographic spread. 
Additional research was conducted in Delhi (National Capital Territory) and in the state of 
Uttar Pradesh. We also conducted desk research regarding palliative care availability in 
various other states. 
 
Over the course of five weeks in the field, Human Rights Watch researchers conducted 111 
interviews with a wide variety of stakeholders, including 38 people with cancer, HIV/AIDS 
patients, and a variety of other life-limiting health conditions; 59 healthcare workers, 
including oncologists, AIDS doctors, anesthesiologists, palliative care doctors, and 
administrators of hospitals, hospices, and palliative care programs; and drug control and 
health officials. 
 
We made a decision, based on ethical considerations, not to interview people who did not 
have realistic access to basic palliative care and pain treatment services: We felt that it 
would be unethical to ask people to discuss in detail their pain and other symptoms or 
their—often terminal—illness if they had no possibility of accessing appropriate professional 
help. As a result, the patients we interviewed were privileged compared to the average 
patient with life-limiting disease in India in that they had gained access to palliative care 
services (although many had experienced long periods without such access and had 
consequently experienced terrible suffering). The picture that can be construed from our 
interviews therefore does not fully capture the deprivation and anguish caused by poor 
availability of palliative care and pain treatment services.  
 
One implication of this decision was that we conducted our research mostly in states and at 
healthcare institutions with some form of palliative care. In West Bengal, where the dearth of 
palliative care and pain management provision was particularly severe at the time, we did 
not seek to interview any patients, instead focusing on healthcare workers and government 
officials. 
 
Most interviews with patients were conducted at healthcare institutions such as hospitals 
and palliative care providers, or in communities at ad hoc outpatient clinics or in palliative 
care patients’ own homes. At healthcare facilities we interviewed both outpatients and 
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inpatients. Where possible, interviews were conducted in private. Interviews were semi-
structured and covered a range of topics related to palliative care and pain treatment. Before 
each interview we informed interviewees of its purpose, informed them of the kinds of 
issues that would be covered, and asked whether they wanted to participate. We informed 
them that they could discontinue the interview at any time or decline to answer any specific 
questions, without consequence. No incentives were offered or provided to persons 
interviewed. We have disguised the identities of all patients we interviewed in this report to 
protect their privacy. The identities of some other interviewees have also been withheld at 
their request. 
 
Interviews with healthcare workers and officials were conducted in English. Most interviews 
with patients were conducted in local languages—Bengali, Hindi, Malayalam, Rajasthani, 
Telegu, and Urdu—with the assistance of translators. All translators we used were affiliated 
with local palliative care programs to ensure that they understood the sensitivities of 
interviewing patients with serious illnesses as well as the basics of palliative care and pain 
management. 
 
In July 2009 Human Rights Watch wrote detailed letters summarizing the findings of its 
research to the Ministry of Health and Family Welfare and the Medical Council of India, 
inviting them to respond to the findings and offering to present comments in this report. 
Copies of the letters are included in this report in Annexes 4 and 5. When this report went to 
print in early October 2009, no responses had yet been received.  
 
All documents cited in the report are either publicly available or on file with Human Rights 
Watch. 
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A Brief Introduction to Palliative Care and Pain Treatment 
 
Palliative care seeks to improve the quality of life of patients and their families facing life-
limiting illness. Unlike curative healthcare, its purpose is not to cure a patient or extend his 
or her life. Palliative care prevents and relieves pain and other physical, psychosocial, and 
spiritual problems. As a quote by Dame Cicely Saunders, the founder of the first modern 
hospice and a lifelong advocate for palliative care, on the wall of a palliative care unit in 
Hyderabad, India, proclaims: palliative care is about “adding life to the days, not days to the 
life.” The World Health Organization recognizes palliative care as an integral part of 
healthcare for cancer, HIV/AIDS, and various other health conditions, that should be 
available to those who need it.5 While palliative care is often associated with cancer, a much 
wider circle of patients with health conditions that limit their ability to live a normal life can 
benefit from it, including patients with dementia, heart, liver or renal disease, or chronic and 
debilitating injuries. 
 
One key objective of palliative care is to offer patients relief from pain. Chronic pain is a 
common symptom of cancer and HIV/AIDS, as well as various other health conditions.6 
Research consistently finds that 60 to 90 percent of patients with advanced cancer 
experience moderate to severe pain.7 Prevalence and severity of pain usually increase with 
disease progression: Several researchers have reported that up to 80 percent of patients in 
the last phase of cancer experience significant pain.8 Pain symptoms are a problem for a 
significant proportion of people living with HIV, even as the increasing availability of 
                                                          
5 WHO, “National Cancer Control Programmes: Policies and Managerial Guidelines, second edition,” pp. 86-87. 
6  Pain is also a symptom in various other diseases and chronic conditions and acute pain is often a side-effect of medical 
procedures. This paper, however, focuses on pain and other symptoms due to life-limiting illnesses.  
7 C.S. Cleeland, J.L. Ladinsky, R.C. Serlin, and N.C. Thuy, “Multidimensional Measurement of Cancer Pain: Comparisons of U.S. 
and Vietnamese Patients,” Journal of Pain and Symptom Management , vol. 3, no. 1 (1988), pp. 23-27; C.S. Cleeland, Y. 
Nakamura, T.R. Mendoza, K.R. Edwards, J. Douglas, and R.C. Serlin, “Dimensions of the Impact of Cancer Pain in a Four Country 
Sample: New Information from Multidimensional Scaling ,” Pain , vol. 67 (1996), pp. 2-3 and 267-273; R.L. Daut and C.S. 
Cleeland, “The prevalence and severity of pain in cancer,” Cancer, vol. 50 (1982), 1913-8; K.M. Foley, “Pain Syndromes in 
Patients with Cancer,” in K.M. Foley, J.J. Bonica, and V. Ventafridda, eds., Advances in Pain Research and Therapy (New York: 
Raven Press, 1979), pp. 59-75; K.M. Foley, “Pain Assessment and Cancer Pain Syndromes,” in D. Doyle, G.W.C Hanks, and N. 
MacDonald, eds., Oxford Textbook of Palliative Medicine, 2nd edition (New York: Oxford University Press, 1979), pp. 310-331; 
J. Stjernsward and D. Clark, “Palliative Medicine: A Global Perspective,” in D. Doyle, G.W.C. Hanks, N. Cherny, and K. Calman, 
eds., Oxford Textbook of Palliative Medicine, 3rd edition (New York: Oxford University Press, 2003), pp. 1199-1222.  
8  K.M. Foley, J.L. Wagner, D.E. Joranson, and H. Gelband, “Pain Control for People with Cancer and AIDS,” Disease Control 
Priorities in Developing Countries, 2nd edition (New York: Oxford University Press, 2006), pp. 981-994; Francois Larue et al., 
“Underestimation and under-treatment of pain in HIV disease: a multicentre study,” British Medical Journal, vol. 314, no. 13, 
1997, http://www.bmj.com/cgi/content/full/314/7073/23 (accessed April, 2007); J. Schofferman and R. Brody, “Pain in Far 
Advanced AIDS,” in K.M. Foley, J.J. Bonica, and V. Ventafridda, eds., Advances in Pain Research and Therapy (New York: Raven 
Press, 1990), pp. 379-386; E.J. Singer, C. Zorilla, B. Fahy-Chandon, S. Chi, K. Syndulko, and W.W. Tourtellotte, “Painful 
Symptoms Reported by Ambulatory HIV-Infected Men in a Longitudinal Study,” Pain, vol. 54 (1993), pp. 1 and 15-19. 
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antiretroviral drugs in middle- and low-income countries is prolonging lives.9 With the advent 
of antiretroviral drugs (ART), the international AIDS community has understandably been 
strongly focused on bringing treatment to people living with HIV. Unfortunately, this has led 
to a widespread but incorrect perception that these people no longer needed palliative care. 
In fact, various studies have shown that a considerable percentage of people on ART 
continue to experience pain and other symptoms and that simultaneous delivery of 
palliative care and ART improves treatment adherence.10 Other conditions such as chronic 
disease or lasting injuries due to accidents or violence are also frequently associated with 
significant chronic pain.11 
 
Moderate to severe pain has a profound impact on quality of life. Persistent pain has a 
series of physical, psychological, and social consequences. It can lead to reduced mobility 
and consequent loss of strength; compromise the immune system; and interfere with a 
person’s ability to eat, concentrate, sleep, or interact with others.12 A WHO study found that 
people who live with chronic pain are four times more likely to suffer from depression or 
anxiety.13 The physical effect of chronic pain and the psychological strain it causes can even 
influence the course of disease: as the WHO notes in its cancer control guidelines, “Pain can 
kill.”14 Social consequences include the inability to work, care for children or other family 
members, participate in social activities, and bid farewell to loved ones.15 
 
According to the WHO, “Most, if not all, pain due to cancer could be relieved if we 
implemented existing medical knowledge and treatments” (original emphasis).16 The 
mainstay medication for the treatment of moderate to severe pain is morphine, an 
inexpensive opioid that is made of an extract of the poppy plant. Morphine can be injected 
                                                          
9 P. Selwyn and M. Forstein, “Overcoming the false dichotomy of curative vs. palliative care for late-stage HIV/AIDS,” JAMA, 
vol. 290 (2003), pp.806-814. 
10 See K. Green, “Evaluating the delivery of HIV palliative care services in out-patient clinics in Viet Nam, upgrading 
document,” London School of Hygiene and Tropical Medicine, 2008.  
11 WHO estimates that worldwide 0.8 million people suffer from moderate to severe pain with adequate treatment due to 
injuries caused by accidents or violence. While many of these people will not require palliative care, those who develop a 
chronic condition associated with pain may. 
12 F. Brennan, D.B. Carr, and M.J. Cousins, “Pain Management: A Fundamental Human Right,” Anesthesia & Analgesia, vol. 
105, no. 1, July 2007, pp. 205-221. 
13 O. Gureje, M. Von Korff, G.E. Simon, R. Gater, “Persistent pain and well-being: a World Health Organization study in primary 
care,” JAMA, vol. 280 (1998), pp. 147-151. See also B. Rosenfeld et al., “Pain in Ambulatory AIDS Patients. II: Impact of Pain on 
Psychological Functioning and Quality of Life,” Pain, vol. 68, no. 2-3 (1996), pp.323-328. 
14 WHO, “National Cancer Control Programme: Policies and Managerial Guidelines, second edition,” p. 83. 
15 R.L. Daut, C.S. Cleeland, and R.C. Flanery, “Development of the Wisconsin Brief Pain Questionnaire to Assess Pain in Cancer 
and Other Diseases,” Pain, vol. 17, no. 2 (1993), pp. 197-210. 
16 WHO, “Achieving Balance in Opioid Control Policy: Guidelines for Assessment,” 2000, p. 1. 
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and taken orally. It is mostly injected to treat acute pain, generally in hospital settings. Oral 
morphine is the drug of choice for chronic pain, and can be taken both in institutional 
settings and at home. Morphine is a controlled medication, meaning that its manufacture, 
distribution, and dispensing is strictly regulated both at the international and national 
levels. 
 
Medical experts have recognized the importance of opioid pain relievers for decades. In 
recognition of this fact, the 1961 Single Convention on Narcotic Drugs, the international 
treaty that governs the use of narcotic drugs, explicitly states that “the medical use of 
narcotic drugs continues to be indispensable for the relief of pain and suffering” and that 
“adequate provision must be made to ensure the availability of narcotic drugs for such 
purposes.”17 The World Health Organization has included both morphine and codeine (a 
weak opioid) in its Model List of Essential Medicines, a list of the minimum essential 
medications that should be available to all persons who need them. 
 
Yet, approximately 80 percent of the world population has either no or insufficient access to 
treatment for moderate to severe pain and tens of millions of people around the world, 
including around 5.5 million cancer patients and one million end-stage HIV/AIDS patients, 
suffer from moderate to severe pain each year without treatment.18 
 
But palliative care is broader than just relief of physical pain. Other key objectives of 
palliative care may include the provision of care for other physical symptoms and 
psychosocial and spiritual care to both the patient and her family. In addition to pain, life-
limiting illness is frequently associated with various other physical symptoms, such as 
nausea and breathlessness, that have significant impact on a patient’s quality of life. 
Palliative care seeks to alleviate these symptoms. 
 
People with life-limiting illness and their relatives often confront profound psychosocial and 
spiritual questions as they face life-threatening or incurable and often debilitating illness. 
Anxiety and depression are common symptoms among patients with life-limiting illness.19 
                                                          
17 United Nations Economic and Social Council (ECOSOC), "Single Convention on Narcotic Drugs of 1961, as amended by the 
1972 Protocol amending the Single Convention on Narcotic Drugs, 1961," preamble, 
http://www.incb.org/incb/convention_1961.html (accessed January 15, 2009). 
18  WHO Briefing Note, “Access to Controlled Medications Programme,” February 2009, 
http://www.who.int/medicines/areas/quality_safety/ACMP_BrNoteGenrl_EN_Feb09.pdf (accessed July 17, 2009). 
19 A 2006 literature review that compared prevalence of eleven common symptoms among patients with five advanced stage 
life-limiting illnesses found that studies reported depression prevalence of 3 to 77 percent in patients with advanced cancer, 
10 to 82 percent in AIDS patients, 9 to 36 percent in patients with heart disease, 37 to 71 in patients with chronic obstructive 
pulmonary disease, and 5 to 60 in renal patients. For anxiety, reviewed studies reported prevalence of 13 to 79 percent in 
patients with advanced cancer, 8 to 34 percent in AIDS patients, 49 percent in patients with heart disease, 51 to 75 in patients 
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Palliative care interventions like psychosocial counseling have been shown to considerably 
diminish incidence and severity of such symptoms and to improve the quality of life of 
patients and their families.20 
 
The WHO has urged countries, including those with limited resources, to make palliative 
care services available. It has pointed out that in “countries with limited resources, it is not 
logical to provide extremely expensive therapies that may benefit only a few patients, while 
the majority of patients presenting with advanced disease and urgently in need of symptom 
control must suffer without relief.”21 It recommends that countries prioritize implementing 
palliative care services in the community—providing care at people’s homes rather than at 
healthcare institutions—where it can be provided at low cost and where people with limited 
access to medical facilities can be reached, and in medical institutions that deal with large 
numbers of patients requiring palliative care services.22 
                                                                                                                                                                             
with chronic obstructive pulmonary disease, and 39 to 70 percent in patients with renal disease. J.P. Solano, B. Gomes, I.J. 
Higginson, “A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive 
Pulmonary Disease and Renal Disease,” Journal of Pain and Symptom Management, Vol 31 No 1 (2006). 
20 See, for example,  WHO, “National Cancer Control Programme: Policies and Managerial Guidelines, second edition,” p. 83-
91. 
21  WHO, “National Cancer Control Programme: Policies and Managerial Guidelines, second edition,” p. 86. 
22  Ibid., pp. 91-92. 
      15       Human Rights Watch | October 2009 
 
Palliative Care and Pain Treatment in India 
 
More than seven million people with life-limiting illnesses may need palliative care services 
in India each year.23 For many, physical pain is the symptom of their most immediate 
concern: Experts estimate that roughly 1 million cancer patients24 and hundreds of 
thousands of people living with HIV and AIDS face moderate to severe pain each year.25 
Other common symptoms of these incurable diseases include nausea, breathlessness, 
anxiety, and depression. 
 
The vast majority of India’s population, however, does not have access to palliative care 
services: such services exist in only 14 of India’s 35 states and territories, according to 
Pallium India, one of India’s leading palliative care organizations.26 Even in many regions 
where palliative care services do exist they are thinly spread, limited to a small number of 
medical institutions, and unavailable in communities. To date, Kerala is the only Indian state 
where palliative care services are available in every district.27 
 
India’s low consumption28 of morphine is indicative of the poor availability of palliative care. 
In 2008 India used an amount of morphine that was sufficient to adequately treat during 
                                                          
23 WHO estimates that on average about 60 percent of people who die would benefit from palliative care before death. See 
Stjernsward and Clark, “Palliative Medicine: A Global Perspective” in Doyle et al, eds., Oxford Textbook of Palliative Medicine, 
3rd edition. In India, with a population of 1.17 billion and a death rate of 6.4 per 1,000 (US Central Intelligence Agency, The 
World Fact Book, 2009, https://www.cia.gov/library/publications/the-world-factbook/geos/in.html (accessed September 1, 
2009)) this translates to an estimated 7.5 million individuals each year who could benefit from palliative care. Data collected 
by the Neighborhood Network in Palliative Care in Kerala over the course of recent years from 60 villages with community-
based palliative care programs consistently shows that about 70 people for every 10,000 population require palliative care. 
Human Rights Watch email correspondence with Dr. Suresh Kumar of the Institute of Palliative Medicine, Calicut, Kerala, July 
23, 2009. 
24 M.R. Rajagopal and D.E. Joranson, “India: opioid availability – an update,” Journal of Pain and Symptom Management, vol. 
33, no. 5 (2007), pp. 615-622. 
25 Approximately 2.47 million people in India are estimated to be living with HIV or AIDS. Two studies conducted in India show 
that palliative care needs among Indians living with HIV are high, with a considerable percentage of those surveyed reporting 
pain and other symptoms. See S.N. Nair, T.R. Mary, S. Prarthana, and P. Harrison, “Prevalence of pain in patients with 
HIV/AIDS: A cross-sectional survey in a South Indian state,” Indian Journal of Palliative Care, vol. 15 (2009), pp. 67-70, 
http://www.jpalliativecare.com/article.asp?issn=0973-
1075;year=2009;volume=15;issue=1;spage=67;epage=70;aulast=Nair (accessed July 21, 2009); and Human Rights Watch 
correspondence with Dr. Gayatri Palat, Hyderabad, regarding survey of pain and other symptoms among people living with HIV 
and AIDS in Andhra Pradesh, June 10, 2009. 
26 See the Pallium India website, http://www.palliumindia.org/clinics.htm (accessed July 17, 2009). 
27 See http://www.painandpalliativecare.org/ and http://www.palliumindia.org/kerala.htm (both accessed July 17, 2009) for 
overviews of palliative care providers in Kerala.  
28 Under article 1 of the 1961 Single Convention on Narcotic Drugs, narcotic drugs are considered to have been “consumed” 
when they have been “supplied to any person or enterprise for retail distribution, medical use or scientific research.” 
Countries are obliged to report their annual consumption of narcotic drugs based on that definition (article 19). 
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that year only about 40,000 out of the estimated 1 million patients suffering from moderate 
to severe pain due to advanced cancer, about 4 percent of those requiring it.29 If one takes 
into consideration other patients who suffer from such pain, like people with cancer that is 
not advanced, HIV and AIDS, and various other conditions, the actual coverage of pain 
treatment with morphine is considerably lower. 
 
Even though the majority of cancer and HIV patients in India require palliative care services, 
most cancer hospitals and HIV clinics have no palliative care departments, do not offer any 
palliative care services, and do not even stock morphine. Eighteen of India’s twenty-nine 
regional cancer centers—cancer centers that are supposed to offer comprehensive cancer 
care—have no palliative care. None of the country’s growing network of ART centers and 
community care centers specifically provides palliative care (although some of the 
counseling services that are offered could qualify as palliative services). None have 
morphine or other medications to treat moderate to severe pain.30 One study that looked at 
prevalence of pain and other symptoms among people living with HIV found that only about 
a quarter of HIV patients reporting pain had received any kind of pain treatment.31 
 
Palliative care in the community 
While Kerala has a sprawling network of community-based palliative care groups that 
penetrate deep into many of the state’s communities, and care for thousands of patients at 
their homes at any given time, in the rest of the country community-based palliative care is 
available only in isolated pockets, leaving the vast majority of patients without realistic 
access to such care (Kerala’s overall population is about 3 percent of the national total). 
                                                          
29 Based on mortality data for cancer, one can calculate approximately how much morphine is needed to adequately treat for 
pain all persons dying of cancer. According to Foley and others, about 80 percent of terminal cancer patients and 50 percent  
of terminal HIV/AIDS patients will suffer from moderate to severe pain for an average period of 90 days. See Foley et al., “Pain 
Control for People with Cancer and AIDS,” in Disease Control Priorities in Developing Countries, 2nd edition, pp. 981-994. 
They will require an average daily dose of 60 to 75 milligrams of morphine. According to India’s latest cancer mortality figures, 
from 2002, 109 people per 100,000 die of cancer per year (http://www.who.int/whosis/en/index.html, customized search, 
accessed June 9, 2009). Using an average daily dosage of 67.5 milligrams per patient, India would require more than 6,000 
kilograms of morphine per year to treat terminal cancer patients for pain. In 2008 the Government Opium and Alkaloid Works, 
the sole agency in India that distributes morphine for domestic consumption, reported that it had distributed 237.5 kilograms 
of morphine (the report is on file with Human Rights Watch). Using Foley’s formula, this amount would suffice for just 39,095 
terminal cancer patients with pain symptoms, or about 4 percent of terminal cancer patients who need pain treatment. The 
Indian government reported to the International Narcotics Control Board that India had consumed 693 kilograms of morphine 
in 2007. See International Narcotics Control Board (INCB), Narcotic Drugs: Estimated World Requirements for 2009 - Statistics 
for 2007 (United Nations: New York, 2009), http://www.incb.org/incb/en/narcotic_drugs_2008.html (accessed August 31, 
2009). We do not use this figure in our calculations because it includes not just morphine used for retail purposes but also 
morphine used by the pharmaceutical industry to produce other medications. It is not known how much of the 693 kilograms 
was used for what purpose. 
30 Human Rights Watch meeting with the National AIDS Control Organization, Delhi, February 13, 2009. 
31 Nair et al., “Prevalence of pain in patients with HIV/AIDS: A cross-sectional survey in a South Indian state,” Indian Journal of 
Palliative Care, vol. 15 (2009), http://www.jpalliativecare.com/article.asp?issn=0973-
1075;year=2009;volume=15;issue=1;spage=67;epage=70;aulast=Nair, pp. 67-70. 
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According to Dr. Suresh Kumar of the Institute of Palliative Medicine in Kerala, there are a 
total of 238 palliative care units in Kerala which he estimates reach about 40 percent of 
Kerala’s population. In the rest of India, there are only about 70 palliative care units, which, 
he estimates, reach less than one percent of needy patients.32 (The elements of  Kerala’s 
different approach are discussed in chapter IV).  
                                                          
32 Human Rights Watch email correspondence with Dr. Suresh Kumar, April 2009.  
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The Plight of Patients33 
 
The Suffering Caused by Untreated Pain 
Relieve my pain or let me die. 
—Zaid, a patient at Hyderabad cancer hospital, Andhra Pradesh, writhing 
with pain before receiving pain treatment34 
 
It felt as if someone was pricking me with needles. I just kept crying 
[throughout the night]. With that pain you think death is the only solution.  
—Priya, Hyderabad35 
 
As we note in the overview, above, the physical, psychological, and social consequences of 
moderate to severe pain on individuals have been documented extensively. In interviews 
with Human Rights Watch, patients in India who had experienced pain described these 
consequences, but they also described something that is not easily captured in quantitative 
studies: the personal and family tragedies that each case represents and the overwhelming 
sense of despair that many experience at being trapped by relentless pain, fear, and 
anguish. 
 
The testimony of Sherin, a construction worker in Kerala who suffered spinal cord injury, is 
typical. He told Human Rights Watch: 
 
I was in an accident at a construction site on 9 August 2004. A wall collapsed 
on me. People dragged me to the medical college hospital. For two days I had 
agonizing pain both in the back and the front. I felt like I was going very 
weak. I asked to see my children because I thought I would die.  
 
I was told that I would be OK ... The doctors said that the pain would go away 
[by itself]. There was no need to medicate it. I was on an IV and was given 
                                                          
33 This chapter focuses mostly on pain symptoms, as these were often the most immediate and urgent symptoms patients had 
experienced and their remarks about them dominated most of our interviews. This focus is in no way meant to downplay or 
trivialize the suffering patients experienced due to other physical and psychological symptoms or to social and spiritual 
distress. Indeed, many patients raised these issues, which, just as pain symptoms, were generally not addressed adequately 
at healthcare institutions that did not offer palliative care. 
34 Human Rights Watch interview with Zaid Ahmed (pseudonym), Hyderabad, March 26, 2008. 
35 Human Rights Watch interview with Priya Chandrapati (pseudonym), Hyderabad, March 25, 2008. 
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lots of medicines. But I was told that no medications were needed for the 
pain. I was screaming all through the night. 
 
The second week I started wasting, losing weight. I became skin and bone. I 
thought I wouldn’t survive. Terrible back pain continued. I was propped up 
onto four or five pillows and told not to turn onto my side. I was very afraid. 
Between the fear and the pain the suffering was intolerable.36 
 
Many of these patients and their caregivers expressed a sentiment that Human Rights Watch 
commonly encounters when interviewing victims of police torture: They would do anything 
whatsoever to make the pain stop. In cases of police torture, many victims sign a confession 
to make that happen. Patients with severe pain whose doctors do not know how to treat it or 
have no access to medications like morphine often see death as the only way out. 
 
Lakshmi Prasad of Trivandrum, Kerala, told Human Rights Watch that pain immobilized her 
late husband, a bone cancer patient, first forcing him to quit his job and then confining him 
to his chair most of the time as he could no longer lie down. At one point, his suffering 
became so bad that he told her he was going to jump off a building to commit suicide.37 
Srinivas Padakanti, a 16-year-old Hyderabad boy with osteosarcoma, a bone cancer, told 
Human Rights Watch that he had had “hellish pain” in his leg at the place of the malignancy 
before he was referred to a palliative care clinic. He said that the pain would drive him mad 
and made him suicidal.38 
 
A number of doctors and other healthcare workers we interviewed also recounted stories of 
patients who saw death as the only way to end their suffering. Dr. Partha Basu of 
Chittaranjan National Cancer Institute in Kolkata, West Bengal, for example, told Human 
Rights Watch, “Even yesterday, there was a woman who had a terminal case of ovarian 
cancer. She was in terrible pain. The only thing she wanted was medicine to die.”39 An HIV 
counselor in Kolkata recalled a 50-year-old patient with HIV and cancer who was in such pain 
that he asked the counselor for poison so he could end his life.40 
 
                                                          
36 Human Rights Watch interview with Sherin Mathew (pseudonym), Kerala, March 20, 2008. 
37 Human Rights Watch interview with Lakshmi Prasad (pseudonym), Trivandrum, March 21, 2008. 
38 Human Rights Watch interview with Srinivas Padakanti (pseudonym), Hyderabad, March 25, 2008. 
39 Human Rights Watch interview with Dr. Partha Basu, head of the Gynecologic Oncology Department, Chittaranjan National 
Cancer Institute, Kolkata, March 25, 2008. 
40 Human Rights Watch interview with Haran, a peer counselor at the SPARSHA Drop-In Center, Kolkata, March 28, 2008. 
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Dilawar Joshi, a Nepali man in Hyderabad with a painful tumor in the leg, told Human Rights 
Watch that he wanted doctors to amputate his limb to stop the pain. He said: 
 
My leg would burn like a chili on your tongue. The pain was so severe I felt 
like dying. I was very scared. I felt that it would be better to die than to have 
to bear this pain. [I thought] Just remove the leg, then it will be alright. Just 
get rid of the leg so I’ll be free of pain.41 
 
Patients told Human Rights Watch that physical pain led to severe strain within their 
families. For example, in Hyderabad, Narasimha Rao, a 45-year-old man with colon cancer, 
said that pain led him to become angry: “I would shout at my wife and hit my children.”42 
Srinivas Padakanti, the Hyderabad boy with bone cancer, said that when he was in severe 
pain he became very angry. He said he beat even his mother, his primary caregiver.43 Kamala 
Kanwar, a woman of about 40 from Rajasthan who has cervical cancer, said that when she 
was in severe pain she did not want to see her children because any kind of noise irritated 
and angered her.44 
 
The Contrast: When Patients Do Gain Access to Pain Management 
I came here [to the palliative care clinic] and took morphine. I felt like Dr. 
Rajagopal and Dr. Suresh restored my life.  
—Prakash Kumar, a cancer patient in Calicut, Kerala45 
 
Most physical suffering is avoidable when doctors have access to medications like morphine 
and have basic pain management skills. Similarly, basic counseling and other palliative care 
interventions can prevent or greatly mitigate suffering due to psychosocial symptoms. 
Indeed, many of the patients mentioned above told us how dramatically their quality of life 
had changed once they received access to palliative care services. 
 
Zaid, the patient quoted at this chapter’s opening, calmed down shortly after he was 
administered morphine.46 Priya told Human Rights Watch: “When I get morphine, I want to 
                                                          
41 Human Rights Watch interview with Dilawar Joshi (pseudonym), Hyderabad, March 26, 2008. 
42 Human Rights Watch interview with Narasimha Rao (pseudonym), Hyderabad, March 28, 2008. 
43 Human Rights Watch interview with Srinivas Padakanti, March 25, 2008. 
44 Human Rights Watch interview with Kamala Kanwar (pseudonym), Jaipur, April 2, 2008. 
45 Human Rights Watch interview with Prakash Kumar (psuedonym), Calicut, March 22, 2008. 
46 Human Rights Watch interview with Zaid Ahmed, March 26, 2008. 
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survive again and see my sons settle.”47 Lakshmi Prasad said that although palliative care 
doctors were not able to completely control her husband’s pain with medications, his life 
became bearable again.48 Dilawar Joshi said that he was “feeling good, comfortable with 
morphine.”49 
 
Another patient, Aneesh Muraleedharan, a 47-year-old man with a stomach cancer, came to 
the palliative care unit at MNJ Institute of Oncology and Regional Cancer Centre (hereinafter 
MNJ Institute of Oncology), Hyderabad, in severe pain in March 2008. As he was waiting to 
see a doctor, Human Rights Watch interviewed his wife. Muraleedharan himself was lying on 
a bed in the corridor writhing in pain, constantly shifting around trying to find a position that 
would provide him some relief, his face contorted. After a doctor saw him, he was admitted 
to the hospital and provided with pain treatment. The next day, Muraleedharan was walking 
around the hospital and, when he saw the Human Rights Watch researcher, came over 
smiling.50 
 
Also in Hyderabad a breast cancer patient, Shruti Sharma, said that she had had severe 
pain—she rated it as 9 on a scale where 10 represents the worst pain imaginable—that badly 
interfered with her sleep. She said, “I would sleep maybe an hour and a half per night. I 
could take any number of sleeping pills [without effect].” With morphine, her pain is under 
control. She said, “This place [the palliative care unit] is heaven-sent ... [With morphine] I 
can relax.”51 
 
In late December 2007 Rohit Sreedharan, a 38-year-old man in Kerala, crashed his 
motorcycle into a concrete post and sustained a broken clavicle. After a week in a hospital 
he was sent home. He had severe pain in his arm. He said, “It was persistent like an electric 
shock.” For the next three weeks he was unable to sleep, and became withdrawn and 
inactive. After he was given morphine and some other medications, his pain was 
significantly reduced, he was able to sleep again, and started exercising his arm to regain 
function of his hand. By the time Human Rights Watch interviewed him in March 2008, 
Sreedharan was able to hold a spoon again and eat for himself.52 
                                                          
47 Human Rights Watch interview with Priya Chandrapati, March 25, 2008. 
48 Human Rights Watch interview Lakshmi Prasad, March 21, 2008. 
49 Human Rights Watch interview with Dilawar Joshi, March 26, 2008. 
50 Human Rights Watch interview with Aneesh Muraleedharan (pseudonym), Hyderabad, March 25, 2008. 
51 Human Rights Watch interview with Shruti Sharma (pseudonym), Hyderabad, March 25, 2008.  
52 Human Rights Watch interview with Rohit Sreedharan (pseudonym), Trivandrum, March 21, 2008. 
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Beyond physical pain 
While physical pain is often the most immediate symptom patients with life-limiting 
diseases face—and the primary focus of this section—most also experience tremendous 
emotional, psychological, and spiritual pain. As M.G. Praveen, a palliative care volunteer 
with the Institute of Palliative Medicine in Kerala, said, “If someone comes to the clinic in 
physical pain, they first want to be out of physical pain. The second phase, they’re free of 
physical pain, but then comes the other pain–social, psychological.”53 With a number of 
basic and inexpensive interventions, palliative care can often provide considerable relief of 
these symptoms. 
Many of the patients Human Rights Watch interviewed expressed deep anxiety and often 
shame related to their illness. As Harmala Gupta, the founder and president of 
CanSupport, a palliative care NGO in Delhi, and a cancer survivor, said, “When you need 
respect and empathy most, you are not treated as a human [but as a carrier of cancer]. 
You’re kicked around from one medical institution to the next, from one procedure to the 
next.”54 
In interviews, patients expressed deep fears about death and dying. For example, Sema, an 
11-year-old girl from Andhra Pradesh with leukemia, told Human Rights Watch that she was 
afraid of what was going to happen to her. She said, “During my stay in Guntur [her home 
district] my parents constantly kept enquiring about the cause of the problem but the 
doctors never told us that it was cancer. They kept saying I would be operated on and that 
they [my parents] had to sign papers. I saw four or five other children die around me. I was 
very scared.”55  
M.G. Praveen told Human Rights Watch, “The first visit [to the patient’s home], we’re 
concerned about the pain or physical symptoms. But the second and third visit, they’re 
opening up their real pain. They don’t know what is going to happen and they want to 
know.”56 
Many patients expressed great anxiety about what would happen to their children once 
they were no longer around. A male patient told us he was concerned he would not be able 
to see his daughters married before he died.57 A woman said she wanted to see her sons 
                                                          
53 Human Rights Watch interview with M.G. Praveen, Calicut, March 21, 2008. 
54 Human Rights Watch interview with Harmala Gupta, president, CanSupport, Delhi, April 3, 2008. 
55 Human Rights Watch interview with Sema Prasad (pseudonym), Hyderabad, February 18, 2009. 
56 Human Rights Watch interview with M.G. Praveen, March 21, 2008. 
57 Human Rights Watch interview with Abdul Kalam (pseudonym), Hyderabad, March 28, 2008. 
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grow up and settle.58 Patients routinely spoke of deep anxieties and feelings of guilt about 
finances. One man said, “I had bought a plot of land for my children. But I’ve had to sell it 
to pay for medical treatment. Now I have nothing to leave my children except debt.”59 
While the effects of psychosocial interventions are harder to measure than of pain 
management, various patients we interviewed told us how important that support from 
palliative care providers had been—or still was—for them. Mohammad, a 39-year-old man 
with multiple myeloma in Kerala, for example, told Human Rights Watch that the 
counseling he received from a palliative care provider “...gave me hope. I wanted to live... I 
have peace in my mind. One day I will surely die but there will be people to care for my 
children and my family.”60 
 
Issues around Gaining Access to Pain Management 
Almost all of the 38 patients we interviewed had initially been denied access to palliative 
care and pain treatment. Although most eventually gained access to such services, they 
generally only did so after being refused adequate treatment at multiple hospitals. Even 
when they did access palliative care, they frequently had to travel long distances, 
complicating its delivery. Denial of palliative care due to its unavailability or inaccessibility 
violates the right to health when it results from government failure to take reasonable steps 
to make it available. In cases where suffering is particularly serious, and the state does not 
take reasonable action within its power to lessen it, the state may be responsible for cruel, 
inhuman and degrading treatment (this is discussed in detail in “The Human Rights 
Analysis,” below). 
 
Denial of palliative care 
Patients described several typical responses when they had discussed their pain and other 
symptoms with doctors at institutions that did not offer palliative care: They said that 
doctors frequently had failed to ask about distressing symptoms, ignored them or dismissed 
them as inevitable, offered inadequate pain treatment, or said that they were addressing 
their cause. Some patients described doctors apparently avoiding them. The lack of 
appropriate training for doctors and the poor availability of morphine in many hospitals and 
pharmacies are among the key reasons for such denial of care (see Chapter IV for more 
                                                          
58 Human Rights Watch interview with Priya Chandrapati, March 25, 2008. 
59 Human Rights Watch interview with Zaid Ahmed, March 26, 2008. 
60 Human Rights Watch interview with Muhammed Khan (pseudonym), Kerala, March 22, 2008. 
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detail). In interviews with Human Rights Watch, several doctors expressed frustration about 
being unable to provide appropriate care to these patients.  
 
Patients’ experiences 
The case of Pillai, an HIV-positive man in Trivandrum, Kerala, is illustrative. Pillai fell ill with 
extrapulmonary tuberculosis of the spine in 2007 and developed severe pain. He told 
Human Rights Watch: 
 
I had pain in my back and both legs. My legs twisted into an abnormal 
position. My legs would turn inside and my toes up. It was a pricking pain 
that was excruciating. I could not sleep as the pain was particularly bad at 
night. 
 
Pillai went to a TB clinic in Trivandrum, where he was given treatment for the TB. When he 
described his excruciating pain, his doctor prescribed him 400 milligrams of ibuprofen, a 
weak painkiller, which, predictably, provided no relief. When he complained to his doctor 
that he continued to have pain his doctor told him, “With this disease, pain doesn’t just go 
away.” At the ART center, where Pillai was receiving antiretroviral treatment for his HIV, 
doctors told him, “Once you get better, the pain will go away.”61 
 
While the kind of nerve pain Pillai suffered is relatively challenging to treat, a trained 
palliative care physician would almost certainly have been able to identify the need to 
relieve Pillai’s pain.62 However, although Pillai received sophisticated medical treatment for 
TB and HIV at two government institutions, his doctors never made any adequate attempt to 
treat his pain. 
 
Other patients said that doctors had given them weak pain medications when their pain was 
moderate to severe. For example, Srinivas Padakanti, the 16-year-old boy with bone cancer 
mentioned above, developed “hellish pain” that prevented him from walking and sleeping.63 
His doctor prescribed weak painkillers but these provided no relief. When Padakanti 
informed the doctor, he was told, “We have given you the tablets.” The doctor apparently felt 
that he had done all he could and that the issue was closed; Padakanti continued to live 
                                                          
61 Human Rights Watch interview with Ganesh Pillai (pseudonym), Trivandrum, March 21, 2008. (With spinal TB, affected 
nerves in the spinal cord can send signals to the legs.) 
62 Human Rights Watch interview with Dr. M.R. Rajagopal, chairman of Pallium India, Kerala, March 21, 2008. 
63 Human Rights Watch interview with Srinivas Padakanti, March 25, 2008. 
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with pain. Only two months later, when he was referred to MNJ Institute of Oncology did he 
begin receiving stronger analgesics that helped him control his pain. 
 
When Reddy, a 47-year-old man with a stomach cancer, complained of persistent and severe 
pain, his doctor in Andhra Pradesh told him, “Cancer means pain. There is nothing we can 
do.”64 Reddy told Human Rights Watch that he rated his pain as 9 on a scale of 10. Sherin 
Mathew, the construction worker mentioned above, was told that there was no need to treat 
his pain as it was caused by internal bruising and would disappear as the swelling went 
down.65 Similarly, when Rohit Sreedharan was hospitalized after his motorcycle accident, 
doctors did not provide him with any pain medications, even though he complained of 
severe pain in one of his arms. He said that the doctors told him, “The pain will be over when 
the clavicle heals.”66 For three weeks he suffered from severe pain until he found a palliative 
care provider and began receiving morphine for his pain. 
 
Although pain is sometimes called the fifth vital sign, few doctors in India, including many 
oncologists, make a habit of asking patients about pain. As noted above, Iqbal, the patient 
with lung cancer, told Human Rights Watch: “They [doctors] sent me here, there, everywhere. 
But nobody ever asked me if I had pain.”67 
 
Dilawar Joshi, the Nepali man with a tumor in the leg, was one of very few people who had 
not brought up his pain with his doctor. He and his wife told Human Rights Watch: “We were 
scared to ask the doctor about the pain. People were shouting and screaming [in the 
hospital]. We were afraid that they might send us home. The doctors didn’t ask.”68 
 
Healthcare workers’ experiences with patients in acute pain 
An AIDS doctor at a large AIDS hospital explained that he and his colleagues tend to focus 
on the cause of the pain in patients because they have no other way of treating it. He told 
Human Rights Watch that “every second or third patient complains of neurological pain” and 
that most advanced AIDS patients have generalized pain. But he had never received any 
training on pain management: “I know how to treat fever, not pain.” Therefore, he said, the 
“focus is on the cause of the pain and trying to treat that.”69 
                                                          
64 Human Rights Watch interview with Sudhir Reddy (pseudonym), Hyderabad, India, March 25, 2008. 
65 Human Rights Watch interview with Sherin Mathew, March 20, 2008. 
66 Human Rights Watch interview with Rohit Sreedharan, March 21, 2008. 
67 Human Rights Watch interview with Muzaffar Iqbal, Hyderabad, India, March 28, 2008. 
68 Human Rights Watch interview with Dilawar Joshi, March 26, 2008. 
69 Human Rights Watch interview. Name withheld. 
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Several healthcare workers who had received training on palliative care but worked at 
hospitals that did not have morphine expressed deep frustration to Human Rights Watch at 
not being able to provide adequate treatment. Rita Panda, a nurse with a clinic for HIV/AIDS 
patients in Kolkata, told Human Rights Watch, “Most patients come here with a lot of pain. 
We use ibuprofen. If morphine could be used that would be much better.”70 Dr. Sarkar of 
Kolkata Medical College told Human Rights Watch he had to improvise with sub-optimal pain 
management strategies because his hospital did not have morphine, although a nearby 
pharmacy did have fentanyl patches, a potent but expensive pain reliever. He said: 
 
I have a patient with extreme generalized bone pain that is not controlled by 
WHO step 1 drugs. I have added weak opioids. The family is not very affluent. 
I prescribed fentanyl patches because the patient was suffering. The pain 
was relieved. After 72 hours, the patient needed a fresh patch, and a fresh 
patch was given. After that, they [the family] couldn’t buy any more–there 
was no money. So they took the patient home ... She never came back.71 
 
Dr. Partha Basu told Human Rights Watch: 
 
The most frustrating thing about it [the lack of morphine] is a feeling of 
helplessness. As a doctor I have a responsibility to give comfort to my 
patient. In my heart I understand that I am not doing what I should be 
doing.72 
 
Several doctors said that healthcare workers at institutions that do not have palliative care 
services frequently seek to avoid patients with severe pain and other symptoms. Dr. 
Durgaprasad of MNJ Institute of Oncology in Hyderabad said this was common at his 
hospital before it started offering palliative care: 
 
We used some drugs ... For example, weak opioids like proxyvon or tramadol. 
But our patients’ pain was [often] much beyond [those medications]. So we 
tried to avoid the patients: “Don’t come to us. Go and take treatment at your 
local [doctor].” That was the attitude. “Our treatment is exhausted. We 
completed radiation, chemotherapy. We did everything we could for you. 
                                                          
70 Human Rights Watch interview with Rita Panda, Kolkata, March 28, 2008. 
71 Human Rights Watch interview with Dr. Shyamal Sarkar, Kolkata, India, March 25, 2008. In a subsequent interview in Delhi, 
on February 13, 2009, Dr. Sarkar told Human Rights Watch that his hospital had since secured a new supply of morphine.  
72 Human Rights Watch interview with Dr. Partha Basu, March 25, 2008. 
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Nothing more is possible. You need not come here. You go and show to your 
local doctor.” The local doctor says, “This is not my specialty. Cancer is like a 
super-specialty. I don’t know anything about this cancer. So go back to your 
treating doctor.” So in between the patient suffers and they die with 
suffering.73 
 
Dr. Sudha Sinha, a medical oncologist at MNJ Institute of Oncology who works mostly with 
pediatric cancer cases, told Human Rights Watch: 
 
There is no data on pain in kids, on where children die, on whether children 
die in pain ... Until recently, I would send children who became incurable 
home, telling their families that no further treatment was possible. I had no 
idea what happened to these children...74 
 
Delayed access to palliative care 
Many patients described a long journey before they were able to access palliative care. This 
journey was often characterized by severe suffering and intense anguish as they dealt with 
healthcare institutions and doctors that were unable or unwilling to provide them proper 
treatment. 
 
Kamala Kanwar, the woman from Rajasthan with cervical cancer, told Human Rights Watch 
that she had spent five months going around to different medical institutions. Her first stop 
was a local doctor in her home town of Bewar, who conducted some diagnostic tests, told 
her there was something wrong with her cervix, and referred her to a public hospital in 
Ajmer. Unhappy with her treatment there, she eventually went to a private gynecologist in 
Bewar who referred her to Bhagwan Mahaveer Cancer Centre in Jaipur. Kanwar said that 
during those five months she had experienced increasingly severe pain: 
 
I developed severe pain all over the abdomen and in the area of my genitals. 
It was a continuous, throbbing pain that radiated to the back. It made me 
very irritable and frustrated. I went back to the doctor three or four times to 
say that I had pain and wasn’t getting any relief. I would get new medicines 
but they would still provide no relief. 
 
                                                          
73 Human Rights Watch interview with Dr. Durgaprasad, MD, Hyderabad, March 24, 2008.  
74 Human Rights Watch interview with Dr. Sudha Sinha, Hyderabad, March 25, 2008. 
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She was unable to get adequate treatment until she arrived at Bhagwan Mahaveer Cancer 
Centre. When Human Rights Watch interviewed her, she said that she had 75 percent less 
pain than before.75 
 
Many palliative care doctors told Human Rights Watch that the majority of their patients 
have a history of untreated pain. For example, the head of the medical oncology department 
at Bhagwan Mahaveer Cancer Centre told Human Rights Watch: 
 
We see many patients who are referred from other hospitals. Many of these 
patients talk about suffering pain before being referred to us. Often, these 
patients will have a 10-page file with medical history without a single 
prescription for pain medications.76 
 
Referral problems at hospitals with palliative care units 
Our research found that even patients at hospitals that have palliative care units sometimes 
unnecessarily suffer from pain and other symptoms. Oncologists do not always refer 
patients with such symptoms to palliative care units while they are still undergoing curative 
treatment. Dr. Durgaprasad of MNJ Institute of Oncology explained, “Doctors associate 
palliative care with the end of life, so don’t see it as part of curative treatment.”77 
 
Zahra Ahmed, a patient with metastatic breast cancer, told Human Rights Watch that she 
was only referred to the palliative care unit at MNJ Institute of Oncologythree months after 
presenting with a recurrence of her cancer: 
 
I was given some medications for pain but I did not have complete relief. It 
was just temporary. Every time I complained the medications [were] changed. 
My pain would be better for three or four hours but then pain would come 
back. I couldn’t sleep because every time I turned I would be in severe pain.78 
 
Only when she was eventually referred to the palliative care unit and put on morphine did 
she get relief. 
                                                          
75 Human Rights Watch interview with Kamala Kanwar, April 2, 2008. 
76 Human Rights Watch interview with Dr. Ajay Bapna, head of the Medical Oncology Department, Bhagwan Mahaveer Cancer 
Center, Jaipur, March 31, 2008. 
77 Human Rights Watch interview with Dr. Durgaprasad, Hyderabad, February 17, 2009. The World Health Organization, 
however, has recommended that palliative care be offered from the moment of diagnosis—see 
http://www.who.int/cancer/palliative/definition/en/ (accessed August 28, 2009). 
78  Human Rights Watch interview with Zahra Ahmed (pseudonym), Hyderabad, March 26, 2008. 
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Long distances to palliative care providers 
We have a ridiculous situation: Oral morphine is so cheap but people have to 
pay 3,000 rupees [about US$60] for travel to get it. 
—Dr. Gayatri Palat, MNJ Institute of Oncology79 
 
Many patients who require palliative care live far away from the nearest provider. This is a 
consequence of both the dearth of palliative care providers in institutional settings and the 
absence of community-based palliative care in most parts of the country. It is also a key 
reason why many of the patients we interviewed were able to access these services only 
after long delays. Yet, palliative care and pain management services can be easily and 
cheaply provided at the local level, both through community-based programs and at primary 
health facilities and hospitals. 
 
Most patients at tertiary cancer hospitals—specialized referral hospitals such as MNJ 
Institute of Oncology in Hyderabad or Bhagwan Mahaveer Cancer Centre in Jaipur—come 
from some distance from the towns in which these hospitals are located. It is not 
uncommon, for example, for patients of the palliative care unit at MNJ Institute of Oncology 
to have to travel nine hours to reach the hospital. While these palliative care units try to find 
ways to serve such patients—by providing a supply of oral morphine for two weeks or a 
month, allowing relatives to pick up medications, or supporting them with travel costs—
comprehensive and effective palliative care and pain management cannot be provided. As 
Dr. Gayatri Palat told Human Rights Watch, “We cannot provide good terminal care. People 
go back to their villages to die.”80 Dr. Anjum Khan Joad, of Bhagwan Mahaveer Cancer 
Centre, echoed this sentiment, saying, 
 
We offer hospital-based palliative care. It is very difficult to maintain contact 
with people in villages. Often we don’t know what happens to patients. Some 
people will call and tell us the patient has died. About some others you read 
in the paper.81  
 
For optimal delivery of palliative care to these patients, community-based programs are 
indispensable, as is availability of morphine at local hospitals and pharmacies. 
 
                                                          
79  Human Rights Watch interview with Dr. Gayatri Palat, MD, Hyderabad, March 24, 2008. 
80 Ibid. 
81 Human Rights Watch interview with Dr. Anjum Joad, anesthesiologist MD, Jaipur, March 31, 2008. 
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Distances also pose a terrible dilemma for the patients. They have to choose between 
difficult travel to receive optimal care, sending relatives—often their only caregivers—to get 
medications, or getting no care at all. The cost of travel is a second dilemma. Patients and 
their families have often already incurred extensive debt paying for diagnostic tests and 
curative care. Even when the palliative care services and medications are offered free of 
charge, travel will drive them deeper into debt.  
 
Various patients Human Rights Watch interviewed described the hardships of having to 
travel long distances to get access to palliative care and pain management. Muzaffar Iqbal, 
the lung cancer patient, lives in a town 500 kilometers from Hyderabad. Although his district 
town has a government hospital, it does not have morphine. He said: 
 
It is difficult for me to have to come all the way here to get pain medications. 
I wish I could get them locally ... because of my leg pain I can’t drive my 
rickshaw anymore. I’m like a beggar. I have to ask neighbors for money and 
food. I have to ask people for money to make trips to pick up my 
medications.82 
 
The exception: Immediate access to palliative care and pain treatment 
A small minority of the patients we interviewed were able to access palliative care and pain 
treatment services almost immediately after developing pain symptoms or being diagnosed 
with a life-threatening condition. These patients had the good fortune, often because they 
lived in Kerala where palliative care is available in many communities, of being referred 
directly to an institution that offers palliative care, or developing a need for palliative care 
only after they were already in the care of such an institution. 
 
One example is Ajai Jayakrishnan, a writer from Kerala with lung cancer. Jayakrishnan 
became ill in the second half of 2007. After a series of tests, he was referred to the regional 
cancer center in Trivandrum, where doctors removed one of his lungs and started him on 
chemotherapy. After several rounds of treatment, he began to develop pain symptoms. His 
doctor started him on painkillers, first weak opioids and later oral morphine.  
 
 
 
 
                                                          
82 Human Rights Watch interview with Muzaffar Iqbal, March 28, 2008. 
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His wife told Human Rights Watch: 
 
We have had no delays in treatment. When my husband was in pain, I would 
call the doctor and he would give us a prescription. For the last few weeks, 
he’s been on oral morphine and generally has good relief.83 
 
As his cancer progressed, a community-based palliative care group began to care for him at 
home, providing medication and counseling to him and his family. A Human Rights Watch 
researcher visited Jayakrishnan together with the palliative care team at his home in March 
2008, where he was bedridden and increasingly weak. 
                                                          
83 Human Rights Watch interview with Nisha Jayakrishnan (pseudonym), Kerala, March 22, 2008. 
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 The Causes of the Palliative Care and Pain Treatment Gap 
 
The World Health Organization has urged countries to adopt national or state policies that 
support pain relief and palliative care; to enact educational programs for the public, 
healthcare personnel, regulators, and other relevant parties; and to modify laws and 
regulations to improve the availability and accessibility of drugs, especially opioid 
analgesics, noting that these measures “cost very little but can have a significant effect.”84 
 
The WHO’s recommendations correspond closely with several core obligations—obligations 
that countries must meet regardless of resource availability—under the right to health. The 
Committee on Economic, Social and Cultural Rights, the body that monitors the 
implementation of the right to health as articulated in the International Covenant on 
Economic, Social and Cultural Rights (ICESCR),85 has held that countries must adopt and 
implement a national public health strategy and plan of action and to ensure access to 
essential drugs as defined by the WHO. 86 It has identified providing appropriate training for 
health personnel as an obligation “of comparable priority.”87 
 
Yet, the Indian government has performed poorly in each of these three areas. While it has, 
to its credit, recommended that states simplify regulations for medical morphine (the 
national Department of Revenue’s recommended “model rule”—see under “Drug 
Availability: The simplified procedure,” below) it has failed to enact meaningful policies 
around the development of palliative care services and has taken no steps to ensure 
education for healthcare workers or the public about palliative care. Most states and 
territories—with the notable exception of Kerala (see below)—have similarly failed to 
develop and enact palliative care policies, to ensure instruction of healthcare workers on 
palliative care, and, despite the recommendation from the central government to simplify 
drug regulations, two-thirds of India’s states and territories have yet to do so. 
 
                                                          
84 WHO, “Cancer Pain Relief, Second Edition, With a guide to opioid availability,” 1996, p. 3. 
85 International Covenant on Economic, Social and Cultural Rights (ICESCR), adopted December 16, 1966, G.A. Res. 2200A 
(XXI), 21 U.N. GAOR Supp. (No. 16) at 49, U.N. Doc. A/6316 (1966), 993 U.N.T.S. 3, entered into force January 3, 1976, art. 11; 
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A/44/49 (1989), entered into force September 2, 1990, art. 12. 
86 UN Committee on Economic, Social and Cultural Rights, “Substantive Issues Arising in the Implementation of the 
International Covenant on Economic, Social and Cultural Rights,” General Comment No. 14, The Right to the Highest Attainable 
Standard of Health, E/C.12/2000/4 (2000), 
http://www.unhchr.ch/tbs/doc.nsf/(Symbol)/40d009901358b0e2c1256915005090be?Opendocument (accessed May 11, 
2006), para. 43. 
87 Ibid., para 44(f). 
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Kerala: A Case Study 
Kerala provides an important example of what is possible in the Indian context. Kerala is 
the only state in India where palliative care services are available in every district, and 
many boast more than a dozen palliative care providers.88 No other state or union territory 
in India comes close to Kerala’s coverage. A combination of an active civil society and a 
responsive government has made Kerala’s success possible. 
 
The development of palliative care in Kerala started in 1993 when the Pain and Palliative 
Care Society (PPCS) of Calicut, with limited support from the government, set up an 
outpatient clinic at the local medical college. Realizing that palliative care would remain 
inaccessible to the majority of the population if it was only offered in healthcare 
institutions, PPCS started exploring ways to bring palliative care into communities. It began 
training doctors, nurses and volunteers and encouraged them to set up link centers. The 
first such center was established in 1996. Since then, their number has grown rapidly. 
Volunteers in the communities have been the backbone of Kerala’s palliative care model. 
They plan and organize the provision of palliative care services, administer day-to-day 
activities, raise funds, attend to the social and financial needs of patients, and organize 
rehabilitation programs for patients and families. 
 
While civil society has been the driving force behind the development of palliative care, the 
government of Kerala has played an important role in facilitating that process. Kerala was 
one of the first states to amend drug regulations to make morphine readily available for 
palliative care providers. In 2008 Kerala became the first Indian state to adopt a state-level 
palliative care policy and to directly fund community-based palliative care programs. 
Yet, considerable challenges remain: More than half of Kerala’s population does not have 
adequate access to palliative care; palliative care remains inadequate or non-existent in 
most healthcare institutions; most medical professionals remain inadequately trained on 
palliative care; and procedures for healthcare providers to obtain injectable morphine 
remain unnecessarily complex. 
 
 
 
 
 
                                                          
88 See http://www.painandpalliativecare.org/ and http://www.palliumindia.org/kerala.htm (both accessed July 17, 2009) for 
overviews of palliative care providers in Kerala.  
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Policy 
Twice in the past 15 years, in 1996 and 2003, the Indian Ministry of Health and Family 
Welfare purchased large quantities of morphine—the last time for 10 million rupees (about 
US$200,000)—for regional cancer centers around the country, using money that had been 
provided by the World Health Organization.89 Consumption of morphine in India had fallen to 
extreme lows in the preceding years—in 1997 India’s per capita consumption of morphine 
ranked 113th of 131 countries that reported statistics90—and the idea was that this purchase 
would help jumpstart the treatment of severe pain symptoms at India’s cancer hospitals. 
However, after the morphine was purchased it remained at the manufacturer for months; the 
majority of the regional cancer centers had not placed orders or refused taking any. When 
the manufacturer asked the government what it should do with the morphine, the 
government gave instructions to send it to Chittaranjan National Cancer Institute in Kolkata 
from where it was supposed to be distributed to other cancer hospitals. Again, most of the 
morphine remained unused as cancer hospitals showed no interest in obtaining any. 
Ultimately, government officials put a seal on the room where morphine was stored, 
apparently to prevent misuse, and prohibited anyone from using it. Most of the morphine 
remained unused and was disposed of after it expired.91 A palliative care expert in India who 
studied these events told Human Rights Watch that most of the regional cancer centers did 
not ask for morphine—or even explicitly refused it—because doctors had not been trained in 
using the medication and because they needed to go through complex licensing procedures 
before being able to get the morphine.92  
 
This failure demonstrates the importance of a coordinated and comprehensive approach to 
improving pain treatment—and palliative care more generally. While the Indian government 
purchased morphine, it had taken inadequate steps to ensure that healthcare workers were 
trained to use it properly or to remove regulatory barriers that impeded the movement of the 
morphine to different hospitals. As a result, a large amount of morphine went to waste while 
hundreds of thousands of cancer patients around India were suffering from severe, 
untreated pain. 
 
                                                          
89 Rajagopal and Joranson, “India: opioid availability – an update,” Journal of Pain and Symptom Management, vol. 33, no. 5 
(2007), pp. 615-622. 
90 Joranson, Rajagopal, and Gilson, “Improving access to opioid analgesics for palliative care in India,” Journal of Pain 
Symptom Management, vol. 24, no. 2 (2002). 
91 Rajagopal and Joranson, “India: opioid availability – an update,” Journal of Pain and Symptom Management, vol. 33, no. 5 
(2007), pp. 615-622; and Human Rights Watch interview with Dr. Partha Basu, March 25, 2008. 
92 Human Rights Watch telephone conversation with with Dr. M.R. Rajagopal, August 27, 2009. 
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Under the right to health, governments have an obligation to play a key role in putting in 
place a coordinated and comprehensive approach to palliative care services. In India, the 
central and most state governments have not played this kind of coordinating and 
facilitating role. 
 
Central government 
India does not have a national palliative care policy. Such a policy is particularly important 
because improving palliative care availability requires simultaneous steps by a range of 
different stakeholders, which, in India, include the Ministry of Health and Family Welfare, 
drugs controllers, the revenue department, hospital administrators, directorates for medical 
education, the Medical Council of India, and state governments. A national policy would 
help ensure that these stakeholders act in a coordinated fashion to improve availability of 
palliative care and pain treatment services, and would also raise the profile of palliative care 
and convey a sense of urgency to its development. 
 
In 2005 the Ministry of Health and Family Welfare initiated a process that could have helped 
to partially fill this void. In the context of the development of the National Cancer Control 
Program (NCCP) for 2007-2011, it appointed a taskforce to formulate recommendations on 
palliative care that were to be included in the NCCP. While India’s national cancer control 
programs have made reference since 1987 to palliative care as a priority for cancer care, this 
rhetorical commitment has never been operationalized: no specific goals or funds were ever 
attached to it. 
 
In April 2006 the taskforce presented its recommendations.93 It proposed that a series of 
steps be taken to improve palliative care availability: 
 
• Policy. The essential nature of palliative care was to be recognized in national and 
state policy by including such language into the National Cancer Control Program 
and striving to include it in state health policies.  
• Palliative care service development. Palliative care provision was to be integrated 
into cancer care offered at all regional cancer centers and 100 other cancer centers 
over the course of the 2007-2011 NCCP. 
• Opioid availability. Simplified narcotics regulations were to be introduced in all 
states and union territories over the course of the five-year plan, and uninterrupted 
                                                          
93 Part of the recommendation is included in Annex 2 to this report. 
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availability of oral morphine was to be ensured at all regional cancer centers and 
cancer centers where palliative care facilities were to be started. 
• Education and training. Training modules for doctors, nurses, social 
workers/counselors, and volunteers were to be developed; education was to be 
provided at regional cancer centers and other cancer hospitals; effective training in 
palliative care was to be ensured in all oncology postgraduate programs, including 
practical exposure; quality assessment tools were to be developed; and at least one 
nodal palliative care training center was to be established in each of India’s five 
geographical regional zones. 
• Advocacy, awareness building, community participation. Peer support groups were 
to be developed for cancer patients and families; public awareness and community 
and NGO participation in palliative care was to be promoted. 
 
Although the Ministry of Health and Family Welfare appointed the taskforce, it never formally 
responded to the recommendations. During the months that the taskforce worked on its 
recommendations, the official in the ministry who had appointed it left and his replacement 
announced at an April 2007 meeting organized by the American Cancer Society that 
palliative care would no longer be necessary in the future as India was about to launch a 
major cancer prevention and early detection campaign.94 At the same meeting India’s 
minister of health told the meeting organized by the American Cancer Society that the total 
budget for the National Cancer Control Plan 2007-2011 would likely be 25 billion rupees 
(about US$500 million).95 The taskforce had estimated the total cost of delivering its 
proposals over five years would be about 460 million rupees (just over $9 million), or less 
than $1 per cancer patient per year.  
 
At this writing, the national cancer control plan for 2007-2011 has not been approved, so it  
is unclear what the final budget will be, and how—if at all—palliative care has been included 
in the program. 
 
The third phase of India’s National AIDS Control Program (NACP), India’s HIV/AIDS strategy, 
and a number of policy documents by the National AIDS Control Organization (NACO) make 
reference to palliative care. For example, NACO’s website states, in its section “Programme 
Priorities and Thrust Areas,” that “NACP-III also plans to invest in community care centres to 
                                                          
94 Human Rights Watch interview with participant of the meeting with the American Cancer Society (name and other 
identifying data withheld). 
95 Letter to the minister of health and family welfare by Dr. M.R. Rajagopal and Poonam Bagai of the palliative care taskforce, 
dated May 4, 2007. A copy of the letter is on file with Human Rights Watch. See also: Nandita Vijay, “Govt increases cancer 
care allocation by 10 fold to Rs 2500 cr under 11th Plan,” Pharmabiz, August 12, 2009, 
http://www.pharmabiz.com/article/detnews.asp?articleid=51155&sectionid (accessed October 5, 2009). 
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provide psycho-social support, outreach services, referrals and palliative care.”96 NACO’s 
guidelines for the response to HIV at the district level state: 
 
The District Hospital will provide the full complement of preventive, 
supportive and curative services. It will provide the whole spectrum of HIV 
related “core and integrated services”: psycho-social counseling and 
support, ART, OI management as out- and in-patient, positive prevention 
services, TB, STI, specialized pediatric HIV care and treatment, palliative care 
and pain management as well as referral for specialist needs such as 
surgery, ENT and ophthalmology etc.97 
 
However, these various documents do not provide any detail on how palliative care services 
are to be implemented in practice. Without a clear plan of action with benchmarks and 
timelines, these references are likely to remain just words. 
 
One positive policy step, the inclusion by the Ministry of Health and Family Welfare of 
morphine—both oral and injectable—on India’s national essential medicines list, appears to 
have had little impact.98 
 
State-level 
Most state governments have played little or no role in the development of palliative care 
services. Where these services do exist, nongovernmental organizations have generally 
taken the initiative to develop them, with state governments playing a passive role. As has 
been mentioned above, the state of Kerala has been the exception. 
 
In Rajasthan and West Bengal, state governments have done little to respond to the 
palliative care needs of the population. They have not adopted palliative care policies or 
even introduced the national Department of Revenue’s recommended “model rule” 
simplifying drug regulations (see below under “Drug Availability: The simplified procedure”). 
In Rajasthan, state government officials participated in a workshop in 2002 to discuss the 
                                                          
96 Official Website of the National AIDS Control Organization (NACO): 
http://www.nacoonline.org/National_AIDS_Control_Program/Programme_Priorities_and_Thrust_Areas/ (accessed July 3, 
2009).  
97  NACO, “Operational Guidelines for District HIV/AIDS Prevention Control Unit,” 2008, 
http://www.nacoonline.org/About_NACO/Policy__Guidelines/ (accessed August 4, 2009). 
98 Directorate General of Health Services, Ministry of Health and Family Welfare, “National List of Essential Medicines 2003,” 
http://cdsco.nic.in/nedl.pdf (accessed august 4, 2009). The preface to the essential medicines list states that the medicines 
included should be “available … at all times in adequate amounts, in the appropriate dosage forms, with assured quality” (p. 
iii). 
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reform of opioid regulations and appointed a taskforce to develop new regulations. But this 
taskforce never produced any result. Such a workshop was also held in West Bengal but 
regulations in the state remain unchanged.99 
 
In August 2009 Andhra Pradesh became the fourteenth Indian state or union territory to 
introduce simplified drug regulations, making it far less complex for healthcare providers to 
obtain morphine.100 However, Andhra Pradesh has not yet adopted a palliative care policy. 
 
Human Rights Watch reviewed the essential medicines lists of Andhra Pradesh and Kerala. 
The former does not contain any opioid medications, including morphine.101 The latter 
includes both weak and strong opioids. It stipulates that tablet morphine should be 
available at all levels of the healthcare system except at primary health centers.102 A 
subsequent July 2009 order of the government of Kerala appears to indicate that morphine 
should become available at primary health centers as well: it states that “regular supply of 
all medicines needed for palliative care” must be ensured at such centers.103 We were 
unable to find essential medicines lists for Rajasthan and West Bengal.  
 
Education 
In 1998, shortly after the central Department of Revenue requested states to change their 
drug regulations and enact a straightforward procedure for obtaining morphine, the state of 
Sikkim did so. Yet, though healthcare institutions in the state should now be able to get oral 
morphine relatively easily, the availability and use of the drug has not improved. Even today, 
more than 10 years after the new rule was introduced, the Indian Association of Palliative 
Care and Pallium India, two leading palliative care organizations in the country, are unaware 
of any palliative care providers in Sikkim, and medical professionals say that pain treatment 
remains unavailable to most patients who need it.104  
 
The reason is simple: The government of Sikkim changed its regulations but it did not take 
steps to provide healthcare workers with training in palliative care and pain management. 
                                                          
99 At this writing, however, the state government of Andhra Pradesh was working with palliative care providers to develop new 
regulations. 
100 A copy of the new regulations is on file with Human Rights Watch. 
101 See http://health.ap.nic.in/nheal/drugs_list.html (accessed July 3, 2009). 
102 Health & Welfare Department, Government of Kerala, “Palliative Care Policy for Kerala,” G O (Rt)No. 2209/1998/H&FWD, 
April 15, 2008, http://www.kerala.gov.in/annualprofile/1480_170408.pdf (accessed August 4, 2009). 
103 Circular of the Government of Kerala, dated July 29, 2009. On file with Human Rights Watch. 
104 Human Rights Watch separate email correspondence with Dr. Anil Paleri, secretary of the Indian Association of Palliative 
Care, and with Dr. M.R. Rajagopal, July 22, 2009. 
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So morphine may have become less difficult to obtain but, without doctors who appreciate 
the importance of the medication, demand for it remains low and most hospitals simply do 
not order it. As a result, thousands of cancer and other patients in Sikkim continue to suffer 
unnecessarily from pain every year. 
 
Human Rights Watch’s interviews in India with doctors who had received palliative care 
training underscored the importance of instruction. Several of these doctors said that the 
training had had enormous impact on their perceptions of palliative care and their ability to 
properly assess and treat patients. Conversely, these doctors said that without adequate 
training doctors are often unable to appreciate the importance of palliative care and pain 
management. Dr. M.R. Rajagopal, a veteran palliative care doctor from Kerala who has 
trained numerous medical doctors on palliative care, told Human Rights Watch: 
 
Until they have received training, doctors do not understand that they are not 
providing good palliative care and pain management. They don’t see the 
pain. They do not understand the importance of morphine. They think they 
are offering appropriate care. They do not feel that there are many obstacles 
to palliative care and pain treatment.105  
 
Dr Partha Basu, head of the gynecologic oncology department of Chittaranjan National 
Cancer Institute in Kolkata, echoed Dr Rajagopal’s sentiment, saying, 
 
I come across a lot of patients in the terminal stage or who are suffering from cancer 
and need pain relief. Eighty percent come in at late stage. More than eighty percent 
[of patients] need some type of pain relief at some time in their life. Once I got 
trained in pain relief and palliative care, I realized the seriousness of the situation. 
Before I just tried with available [weak] analgesics...106 
 
An oncologist from Chittaranjan National Cancer Institute in Kolkata, Dr. Prabeer Chaudhari, 
told Human Rights Watch that a six-week training he underwent with a leading Indian 
palliative care doctor in Hyderabad was an eye-opener. Although he had been a practicing 
radio oncologist for 25 years, it was during this training, he said, that he realized “the need 
to use opiates from the core of my heart.”107 Another doctor, an anesthesiologist with 22 
                                                          
105 Human Rights Watch interview with Dr. M.R. Rajagopal, Trivandrum, March 17, 2008. 
106 Human Rights Watch interview with Dr. Partha Basu, March 25, 2008. 
107 Human Rights Watch interview with Dr. Prabeer Chaudhari, professor of radiation oncology, Kolkata, March 25, 2008. 
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years of experience, said that palliative care training had “completely changed my 
perception about pain treatment.”108 
 
Under the right to health, governments must take reasonable steps to ensure healthcare 
workers have appropriate training on palliative care and pain management. As an integral 
part of care and treatment for cancer and HIV, two key diseases in India, countries need to 
ensure that basic instruction on palliative and pain management is part of undergraduate 
medical studies, nursing school, and continuing medical education. Specialized instruction 
should be available for healthcare workers who pursue a specialization in oncology, HIV and 
AIDS, and other disciplines where knowledge of pain management and palliative care is a 
key part of care.109  
 
Medical education in India 
At present, the undergraduate curriculum for medical education does not include any 
specific instruction on palliative care or pain management. Indeed, even the WHO pain relief 
ladder, the fundamental tool for treating pain, is not taught in most medical colleges.110 
 
Several palliative care doctors commented on the lack of instruction in medical college on 
palliative care and pain treatment. For example, Dr. Nidhi Patni, a radiation oncologist at 
Bhagwan Mahaveer Cancer Centre, told Human Rights Watch, “In medical college, I got zero 
exposure to pain management. In pharmacology, we got the basics on painkillers but that 
was it.”111 She learned about palliative care during her postgraduate studies at Tata Hospital 
in Mumbai. A young oncologist from Delhi told Human Rights Watch: “In medical college, is 
there any discussion of pain management? Absolutely not. We do not get any exposure to 
the principles of palliative care.”112 
 
In postgraduate education, instruction on, and exposure to, palliative care and pain 
management is extremely limited even for students who specialize in oncology or 
anesthesiology. This is a consequence of both the absence of formal training requirements 
                                                          
108 Human Rights Watch interview with Dr. Parvathi, MD, Trivandrum, March 21, 2008. 
109 Human Rights Watch, “Please, do not make us suffer any more…”: Access to Pain Treatment as a Human Right, March 
2009, http://www.hrw.org/en/reports/2009/03/02/please-do-not-make-us-suffer-any-more, p. 26. 
110 Human Rights Watch correspondence with Dr. Sukdev Nayak, president of the Indian Association of Palliative Care, August 
31, 2009. 
111 Human Rights Watch interview with Dr. Nidhi Patni, radiation oncologist, Jaipur, March 31, 2009. 
112 Human Rights Watch interview with an oncologist who requested anonymity, Delhi, February 14, 2009. 
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in official curricula and the lack of palliative care units and pain clinics at teaching hospitals 
where postgraduates could be exposed to clinical practice. 
 
Government agencies have not taken any proactive steps to ensure that instruction in 
palliative care and pain management is taught at medical colleges. Members of the Medical 
Council of India, which sets the curriculum for medical colleges, have told palliative care 
doctors that they believe that the current curriculum is flexible enough to allow medical 
colleges to introduce basic elements of palliative care and pain management to students. 
But the Council has not specifically recommended that medical colleges do so.113 
 
Only a very small number of medical colleges in India—five out of a total of more than 300—
have indeed done so. These medical colleges have incorporated instruction on palliative 
care in the course materials for community health and on pain management into 
anesthesiology.114 
 
Similarly, only a small number of teaching hospitals provide clinical exposure to palliative 
care and pain management to postgraduate students. For example, as noted in chapter II, 
only 11 of 29 regional cancer centers—all of which are teaching hospitals—offer any form of 
palliative care or pain management. Thus, hundreds of oncologists, anesthesiologist, 
nurses, and other medical personnel in training do not receive any practical exposure to 
palliative care or pain management. 
 
The absence of even basic steps to introduce palliative care into relevant curricula is a 
violation of the right to health. 
 
Instruction for HIV/AIDS doctors 
India’s National AIDS Control Organization is engaged in a massive effort to train hundreds 
of doctors and nurses on HIV care and treatment, as India rolls out antiretroviral treatment 
for the estimated 2.5 million Indians living with HIV and AIDS. It has trained doctors and 
nurses working at more than 200 ART centers115 and 96 community care centers.116 
                                                          
113 Human Rights Watch email correspondence with Dr. Suresh Kumar, June 7, 2009. 
114 St. John’s National Academy of Medical Sciences in Bangalore, the first to introduce palliative care instruction for medical 
students, offers a series of five weekly lectures in palliative care to fourth-year medical students and third-year nursing 
students. See Y. Velayudhan et al., “Introduction of palliative care into undergraduate medical and nursing education in India: 
A critical evaluation.” Indian Journal of Palliative Care [serial online] 2004 [cited 2009 Jul 21];10:55-60., 
http://www.jpalliativecare.com/text.asp?2004/10/2/55/13886 (accessed July 21, 2009).  
115 NACO website: 
http://www.nacoonline.org/upload/Care%20&%20Treatment/functional%20ART%20centres%20July%202009.pdf (accessed 
July 31, 2009). 
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However, to date, the training NACO has been providing for HIV/AIDS doctors has not 
included instruction on palliative care and pain management. While the curriculum includes 
instruction on issues like counseling that could also be part of palliative care, it is not taught 
in the broader framework of palliative care and does not include pain management. At a 
meeting with Human Rights Watch in February 2009, the deputy secretary general of NACO 
stated that he was open to starting training for AIDS doctors on pain management and 
palliative care.117 Palliative care providers are currently engaging with NACO to introduce 
palliative care training for HIV/AIDS doctors. 
 
Consequences of inadequate training 
The lack of instruction for healthcare workers not only results in denial of treatment for 
patients, it also perpetuates problems with drug availability, as hospital administrators or 
pharmacists who do not understand the essential nature of morphine for the treatment of 
pain are less likely to ensure that the hospital pharmacies stock morphine. 
 
Human Rights Watch came across several examples of this in our research. For example, a 
young anesthesiologist who had received his postgraduate training at a hospital with an 
active pain clinic told Human Rights Watch of the challenges he faced trying to convince his 
new employer, a private medical college, of the importance of providing palliative care 
services: 
 
The biggest hindrance, I think, is that they [the hospital administration and 
fellow doctors] do not have any concept of palliative care and pain 
management ... If we want [to obtain a morphine license] we can get it. 
Though we can get it with difficulty, we can get it at last. [But] they have no 
idea.118 
 
 
 
 
                                                                                                                                                                             
116 Indian government, UNGASS Country Progress Report, 2008, 
http://data.unaids.org/pub/Report/2008/india_2008_country_progress_report_en.pdf (accessed August 3, 2009). 
117 Human Rights Watch interview with Dr. Damodar Bachani, Delhi, February 12, 2009.  
118  Human Rights Watch interview with anesthesiologist who requested anonymity, Delhi, February 13, 2009. 
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Drug Availability119 
[When our hospital is unable to get morphine] we simply see them [patients] 
writhing in pain. We use non-opioids and weak opioids ... We can prescribe 
fentanyl patches. They cost 400 rupees [about US$8] for ... 72 hours. They’re 
available commercially. They’re out of reach for most of my patients, but  
 
sometimes they have to buy them because people can’t be seen suffering so 
much.  
—Dr. Sarkar, oncologist, Kolkata Medical College, discussing a period of more 
than a year when his hospital was unable to procure morphine120  
 
Since 1985 the Indian government and state governments have enacted excessively 
burdensome regulations to prevent misuse of controlled substances. These regulations are a 
key reason why availability and accessibility of morphine and other opioid analgesics are 
poor in most of India. Although with the Department of Revenue’s 1998 model rule the 
Indian government has recommended a partial change to these rules, many states still 
operate under outdated rules that severely impede availability of morphine. Ironically, India 
is one of the largest producers of licit poppy and a supplier of morphine for much of the rest 
of the world.121 
 
International law, specifically the 1961 Single Convention on Narcotic Drugs, requires that 
governments create a drug control system that both ensures the availability of opioids for 
medical purposes and prevents their illicit manufacture, trafficking, and use.122 In India, the 
1985 Narcotic Drugs and Psychotropic Substances Act (NDPS Act) created its national drug 
control framework. Under the Act,  
 
the cultivation, production, manufacture, possession, sale, purchase, 
transportation, warehousing, consumption, inter-state movement, 
transshipment, and import and export of narcotic drugs and psychotropic 
                                                          
119  Because of its crucial role in palliative care and the considerable problems with accessibility of morphine in India, this 
section focuses on the availability of morphine. Other essential palliative care medications are generally available in 
healthcare settings, although cost remains a considerable barrier for many patients. 
120 Human Rights Watch interview with Dr. Sarkar, February 13, 2009.  
121 Joranson, Rajagopal, and Gilson, “Improving access to opioid analgesics for palliative care in India,” Journal of Pain 
Symptom Management, vol. 24, no. 2 (2002), pp. 152-159. 
122  Preamble of the 1961 Single Convention on Narcotic Drugs, https://www.incb.org/convention_1961.html; and INCB, 
“Availability of Opiates for Medical Needs: Report of the International Narcotics Control Board for 1995,” p. 14, 
http://www.incb.org/pdf/e/ar/1995/suppl1en.pdf (accessed September 25, 2009).  
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substances is prohibited, except for medical or scientific purposes and in 
accordance with the terms and conditions of any license, permit or 
authorization given by the Government.123 
 
Both the central government and state governments play a role in regulating opioid 
medications, with the states “empowered to permit and regulate possession and inter-state 
movement of ... the manufacture of medicinal opium.”124 
 
After the adoption of the NDPS Act, medical use of morphine in India collapsed. In 1985, 
India consumed 573 kilograms of morphine; most of it was used in injectable form in 
hospitals to relieve post-operative pain.125 Over the next decade, consumption of morphine 
dropped by 97 percent and reached a low of just 18 kilograms in 1997.126 As Joranson, 
Rajagopal, and Gilson have pointed out, in that same period global consumption of 
morphine increased by 437 percent.127 
 
Research into the sharp decline of morphine consumption in India by the WHO Collaborating 
Center for Policy and Communications in Cancer Care found that “the laws to control abuse 
of narcotic drugs interfered with making opioids available for medical and scientific 
purposes, and thus, were not balanced.”128 It concluded that two major policy factors 
contributed to this lack of balance: First, the 10-year mandatory minimum prison term for 
violations involving narcotic drugs that the 1985 Act established led to pharmacies all over 
the country dropping morphine from their stock.129 Secondly, states adopted complex 
narcotic rules following the 1985 Act, requiring (in Joranson, Rajagopal, and Gilson’s words) 
“import, import, export and transport licenses to ship any amount of morphine between any 
                                                          
123 Section 10 of the Narcotic Drugs and Psychotropic Substances Act , 1985 (w.e.f. 14.11.1985) amended by The Narcotic 
Drugs and Psychotropic Substances (Amendment) Act, 1988 (Act No. 2 of 1989) (w.e.f. 29.5.1989) and The Narcotic Drugs and 
Psychotropic Substances (Amendment) Act, 2001 (Act No. 9 of 2001) (w.e.f. 2.10.2001). 
124 Ibid. 
125 Joranson, Rajagopal, and Gilson, “Improving access to opioid analgesics for palliative care in India,” Journal of Pain 
Symptom Management, vol. 24, no. 2 (2002). 
126 Ibid. 
127 Ibid. 
128 Ibid. 
129 Since then the law has been amended. At present, violation of the conditions of a narcotic drug license, including the 
failure to keep proper accounts of the use of such drugs, is punishable by up to three years in prison, a fine, or both. It 
appears that unintentional or minor clerical mistakes could thus trigger criminal liability (see section 26). However, it also 
appears that criminal prosecutions of license holders and their staff are rare. In interviews, Human Rights Watch did not come 
across much anxiety among physicians about potential criminal prosecutions for unintentional violations of narcotics rules. 
No other physicians reported any cases of prosecutions of healthcare workers related to the use of medical opioids. 
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two states, as if they were countries.”130 Most pharmacies stopped stocking morphine, and 
those that continued to do so began facing regular interruptions in supply due to the 
cumbersome procedures for procuring morphine. 
 
By the late 1990s the Indian government recognized that the regulations introduced by the 
NDPS Act were impeding the legitimate use of an essential medication, and recommended 
that all states and territories adopt a new model rule that simplified the licensing and 
procurement system for oral morphine. However, under the NDPS Act, state governments are 
empowered to regulate the possession and movement of narcotic drugs and are therefore 
under no obligation to follow the recommendation of the national Department of Revenue. 
Morphine consumption has gradually gone up since the late 1990s, as palliative care 
advocates have trained healthcare workers, set up new palliative care programs, and some 
states introduced the model rule. But according to the Government Alkaloid and Opium 
Works, the sole government agency that distributes morphine domestically, India consumed 
237.5 kilograms of morphine in 2008,131 which is less than half the total consumed in 1985; 
this means that on a per capita basis, morphine consumption today is still just a quarter of 
1985 levels. 
 
Key problems with unamended state regulations: Multiple and complex licensing 
requirements 
Unamended regulations in most states require medical institutions to obtain four or five 
different licenses before morphine or other opioid medications can be legally obtained and 
possessed. As a first step, medical institutions need to obtain a possession license, which 
permits them to stock morphine, along with a quota which specifies the maximum amount 
that the institution can possess during the validity period of the license.132 Once the medical 
institution has obtained a possession license and quota, it can proceed with procurement of 
morphine. For each order, however, other licenses are or may be required: an import license; 
an export license to be obtained by the manufacturer if the latter is located in a different 
state from the procuring party; and, in some states, a transportation license.  
 
The procedure for obtaining these various licenses is complex. It generally involves at least 
two different departments of state government: the department of excise (the equivalent of 
                                                          
130 Joranson, Rajagopal, and Gilson, “Improving access to opioid analgesics for palliative care in India,” Journal of Pain 
Symptom Management, vol. 24, no. 2 (2002). 
131 Newsletter of Pallium India, June 23, 2009, http://www.palliumindia.org/newsletter/newsletter-June2009.pdf (accessed 
July 21, 2009). 
132 In some states, government hospitals are exempt from requiring a possession license. 
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the revenue department on the national level) and the department of health. Under typical 
state regulations, applications are generally lodged with the district excise officer, who is 
entitled to “make enquiries as he deems necessary” while processing the application.133 In 
practice, excise officers always seek the input and approval of the state drugs controller. At 
both the excise department and the drugs controller’s office, applications are generally 
reviewed at multiple levels. (The steps in the process for obtaining possession and 
procurement licences are mapped out in more detail in Appendix 1.) 
 
Obtaining a possession license and quota 
Various doctors and palliative care providers told Human Rights Watch of the difficulties 
they faced obtaining morphine licenses for their institutions. For example, a doctor at a 
medical college in a provincial town in northern India said in February 2009 that he had 
been trying to obtain such a license for his hospital for three months but had made little 
progress: 
 
The local excise office does not know anything about morphine. They don’t know 
the procedure. So they have been dragging their feet. It took a long time for them 
to process the application I had submitted to obtain the license. They just sat on 
it ... When they finally did process it, they did so incorrectly and, as a result, I 
had to start everything again from scratch.134 
 
A doctor in Kerala spoke of the difficulties he faced trying to get a license for injectable 
morphine for his hospital. He said that officials at the excise office had no idea how to 
process his request. Over the course of six months he unsuccessfully tried to learn the 
requirements for the application process, visiting and calling both the local and district 
excise offices. When he eventually just filed the application with the district excise office, he 
was told that he should apply with the local excise office. By that time he had left the 
hospital. As of July 2009, the hospital still did not have a possession license for injectable 
morphine, and the doctor was unsure whether the hospital was still actively pursuing one. 135 
 
Palliative care providers that are not affiliated with a hospital often face particular difficulties 
obtaining a possession license for morphine. Although state regulations generally do not 
                                                          
133 The Andhra Pradesh Narcotic Drugs and Psychotropic Substances Rules 1986 (see Section 16). 
134 Human Rights Watch interview with a doctor who requested that his name and other identifying data be withheld, February 
2009. 
135  Human Rights Watch interview with a doctor who requested anonymity, Kerala, March 21, 2008, and email 
correspondence with same, July 2009. 
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preclude individual palliative care doctors from obtaining licenses for opioids, in practice 
excise officers and drug controllers have often required that palliative care providers be 
formally recognized as medical institutions before granting a license. For example, when 
Santanu Chakraborty, who runs the Ruma Abedona Hospice, a 14-bed hospice and 
community-based palliative care program in Kolkata, applied for a possession license in 
2007, the West Bengal authorities told him to obtain a “clinical establishment” license 
before applying for the possession license. After waiting for more than six months—more 
than twice as long as the maximum period under the simplified narcotics rules 
recommended by the central government—his hospice was recognized as a clinical 
establishment in March 2008.136 
 
CanSupport, an NGO in Delhi that has been providing home-based palliative care since 
1997, faced major obstacles obtaining a possession license for morphine. The founder of the 
organization, Harmala Gupta, told Human Rights Watch that it took almost four years to 
finally secure the license.137 Initially, the rules in Delhi required that in order to obtain a 
license for oral morphine CanSupport be registered either as a hospital or as a nursing 
home; the problem was that it was neither. A long stalemate ensued as the nursing homes 
superintendent did not know what to do with CanSupport. The breakthrough eventually 
came when a new principal secretary for health, a senior government official, in the Delhi 
union territory government, who had personal experience with cancer, took office. When 
CanSupport approached him and explained the problem, he initiated a meeting at which 
agreement was reached to amend the rules as per the recommendations of the Department 
of Revenue. With the new rules in place, the drugs controller recognized CanSupport as a 
registered medical institution and provided it with a possession license for oral morphine. 
Since then, CanSupport has treated more than 3,000 patients and relieved their pain with 
oral morphine. 
 
While the system of allocating a quota with the possession licence is not unreasonable 
itself—provided that the quotas allotted are sufficient—it does create additional problems: 
Because obtaining import licenses, which are needed to procure more morphine, is such a 
complex procedure, medical institutions often wait until their morphine supply is very low 
before they place a new order. This way they can minimize the number of times they need to 
order morphine. The result of this practice is that there is little margin for error or delay in the 
procurement process before an institution will run out of morphine. A doctor at BP Poddar 
Hospital in Kolkata explained: 
                                                          
136 Human Rights Watch interview with Santanu Chakraborty, director of Ruma Abedona Hospice, Kolkata, March 27, 2008. 
137 Human Rights Watch interview with Harmala Gupta, April 3, 2008. 
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 The quota system is strict. Say you’re allowed to have 1,000 10 milligram 
tablets of oral morphine and have used 800. If you apply for more you’ll only 
get the missing tablets replaced. Hospitals will usually exhaust their supply 
before they reorder.138 
 
Initial quotas may be relatively small because the medical institution has no past record of 
consumption that would help establish a reasonable quota. In order to change a quota, a 
healthcare institution has to go through the full procedure for obtaining a possession 
license. 
 
Procuring morphine 
Doctors and pharmacists also expressed frustration at the complexity of procedures for 
procuring morphine. They said that it can take many weeks or even months to obtain all the 
necessary licenses and to fill an order, and that any hiccups in the process can lead to 
interruptions in stock. 
 
A pharmacist for a large private cancer hospital described to Human Rights Watch the 
numerous steps he has to take each time he places an order for morphine (see text box 
below for details). He said that while his pharmacy can generally obtain non-opioid 
medications within a few hours, it usually takes several months to get morphine. If anything 
goes wrong, it can take “up to five or six months.”139 
 
Procuring morphine – A pharmacist’s tale 
Arun is a pharmacist at a large private cancer hospital. His pharmacy has had a license for 
oral and injectable morphine for about 10 years. Over those years, he has had to order 
morphine numerous times. He told Human Rights Watch about the procurement procedure 
and its pitfalls. 
“We’re a hospital. We should get these medications in a day or two, maximum a week. The 
reality is, however, that the process takes several months. 
“The process for procurement is tedious and long. We must apply to the drugs controller for 
an import license. He asks for reports about consumption of old stock, and then provides 
an allocation from a particular manufacturer. Once an allocation is issued, you have to 
                                                          
138 Human Rights Watch interview with Dr. N.D. Manna, Kolkata, March 25, 2008. 
139 Human Rights Watch interview with Arun (pseudonym), April 2008. Place withheld. 
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apply to the excise department. This is a horrible department. 
“Say we apply to the excise department today. It may take 15 visits to the excise office 
before we get the permit. The papers have to move [for approval] from one point within the 
excise department to another. A single mistake—even a spelling error—and they [the excise 
department] will turn the application down. Then you have to reapply. 
“When the import license permit is finally issued, the manufacturer [who is out-of-state] 
must obtain an export license from the excise department in that state. What happens is 
we get the road permit and have to import the morphine by a specified date from a 
specified supplier. The road permit is generally valid for 15 days. We ask for 30 and that 
request is usually granted. We send the order to the company. Mailing it takes some time. 
“Then their process starts. They need an export license from their excise department, 
which takes time. The same thing, there’s some corruption there. In the meantime, our 
license may expire because we can’t finish the process within the specified time. 
“Once the license is expired, we don’t get our order. We will be told, “Your license is 
expired. We can’t send you the medications. Get a new license.” In that case, it takes 
another one or two months. Similarly, if the medications are not in stock, you have to start 
from scratch again [because the license will expire before the order is filled]. In about 20 to 
25 percent of cases, our import license expires before all other licenses are obtained.”140 
 
Doctors said that obtaining the various procurement licenses was a considerable hassle. 
Many said it took repeat visits or phone calls to the excise department to make sure that 
paperwork was actually being processed. They also identified the short validity of the 
various licenses as a key cause of stock-outs. Dr. Sarkar, for example, said, “The transport 
permit is valid only for one month. Sometimes the permit expires before there’s a possibility 
of transport, so we have to go to the excise commissioner again.”141 To illustrate this, Dr. 
Sarkar provided Human Rights Watch with a copy of a letter his hospital had received from a 
morphine manufacturer. The letter reads: 
 
                                                          
140 Human Rights Watch interview. Import licenses specify the manufacturer, type of medication, and its formulation. As 
manufacturers must fill the exact order, problems occur when the manufacturer does not have a supply of the right 
formulation. Given the short validity of licenses, supply problems on the manufacturer’s side almost automatically mean that 
the institution has to reapply for an import license. 
141 Human Rights Watch interview with Dr. Sarkar, February 13, 2009. 
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We are returning the documents with the order forms for the following 
amendments: 1) The permit is valid only till 23.4.2006 which period is not 
enough to get the permission from U.P. [Uttar Pradesh] Excise Department 
which normally takes at least two weeks. In view of the recent transfer 
[illegible] in Meerat all the top officials including the District Magistrate who 
is the head of sanctioning authority is transferred and as such more time is 
needed to process the documents.142 
 
A recent experience of a large cancer hospital provides a good example of how poorly 
attuned these procedures are to the needs of healthcare providers. In late 2008 this hospital 
obtained an import license from the local excise department for a large quantity of morphine 
and placed its order with a manufacturer in a different state. Although the hospital had 
obtained approval from its local excise department, the excise department in the 
manufacturer’s state insisted on an additional inspection of the hospital because of the 
amount of morphine requested. 
 
The local drugs controller sent another inspector to the hospital who took several weeks to 
file his report. The report then had to be approved at four different levels in the drugs 
controller’s office—by the assistant director for the NDPS Act, the additional director for the 
NDPS Act, the director, and then the state drugs controller. When finally approved and filed 
with the excise department in the manufacturer’s state, the manufacturer discovered that its 
address had been incorrectly recorded on the application and all paperwork had to be 
redone. By the time the order was finally filled, the hospital had been without morphine for 
almost three months. It was forced to improvise, giving patients prescriptions to fill at one of 
the private hospitals in town or providing them with weak opioids like codeine or 
tramadol.143 
 
Paradox: Low cost of morphine as an obstacle to its availability 
Morphine can be produced at very low cost. For example, the Indian pharmaceutical 
company Cipla makes 10 milligrams morphine tablets that sell at 0.85 rupee (less than 
US2¢) each. This low cost should make it possible for morphine to be accessible even in 
resource strapped countries. But, paradoxically, the low cost of morphine is one reason 
why its availability in much of India is poor. 
 
                                                          
142 A copy of the letter is on file with Human Rights Watch. 
143 Human Rights Watch interview with hospital official who requested that names and other identifying data be withheld. 
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Because of its low cost, profit margins on morphine for both 
pharmaceutical companies and pharmacies are small, giving the latter little 
incentive to stock the medication—particularly considering the extremely 
complex procedures for procuring it. As Dr. Basu of Kolkata put it, 
“Shopkeepers [pharmacists] say it’s not worth it to store a medication that 
doesn’t bring much profit. They have to face so much harassment and it’s 
not worth it.” 144 
 
He also noted, “The interesting thing is that fentanyl patches are available. But they are 30 
times more costly.” Because of their profitability, pharmaceutical companies have a vested 
interest in encouraging hospitals and pharmacies to stock fentanyl patches and doctors to 
prescribe them. As one form of encouragement, pharmaceutical companies often take care 
of licensing procedures for their clients, removing a key obstacle to the availability of these 
drugs. 
 
The simplified procedure 
In 1998, after becoming aware of the dramatic impact the complex licensing procedures 
were having on pain patients, the national Department of Revenue drafted a model that 
states could use to simplify their rules around medical use of opioids. 
 
The “model rule” eliminates the role of the excise department and limits the number of 
licenses needed to one. Under the model rule, hospitals or medical institutions can file 
applications to the state drugs controller to be granted the status of a “recognized medical 
institution” (RMI), a designation that allows them to procure morphine. They are required to 
submit annual estimates for morphine to the drugs controller and, once these are approved, 
they can order morphine from the specific manufacturer without any further licenses. The 
drugs controller may inspect both the records kept by institutions and their morphine stock, 
and can revoke their status in case of violations of procedure or non-medical use of 
morphine. (A copy of the model rule is included in Annex 1.) 
 
Since 1998 this model rule has only been adopted in 14 out of 35 states and union 
territories.145 (See Map 2) In states like Kerala and Tamil Nadu it has helped to dramatically 
                                                          
144 Human Rights Watch interview with Dr. Partha Basu, March 25, 2008. 
145 MNJ Institute of Oncology and Regional Cancer Centre, “Guidelines for Developing of Palliative Care Services,” 2009. The 
states and union territories that have introduced the model rule are: Andhra Pradesh, Arunachal Pradesh, Delhi, Goa, Haryana, 
Jammu and Kashmir, Karnataka, Kerala, Madhya Pradesh, Orissa, Uttar Pradesh, Sikkim, Tamil Nada, and Tripura. 
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increase availability of oral morphine, as much greater numbers of healthcare institutions, 
including many nongovernmental palliative care providers, are now licensed to stock and 
dispense the medication. In Kerala, for example, around 120 medical institutions have been 
recognized as RMIs and are actively providing morphine to pain patients.146 As mentioned 
above with the example of Sikkim, however, the simplified procedure has not led to an 
increase in morphine consumption in some other states: besides Sikkim, the same is true of 
Jammu and Kashmir, Tripura, and Madhya Pradesh.  
 
A study by M.R. Rajagopal and others in 2001 examined the use of morphine by a number of 
palliative care providers and found no evidence that any of the morphine dispensed through 
the new procedure had been diverted from the licit to the black market.147 The Kerala drugs 
controller told Human Rights Watch that he was satisfied with the new system and had no 
concerns about misuse. He noted that “we need restrictions but we’ve been going to 
extremes.”148 
 
In a number of states, Kerala included, drugs controllers interpret the model rule restrictively 
as applying only to oral morphine, even though the text of the model rule suggests that it 
applies to all formulations of morphine. As a result of this interpretation, palliative care 
providers still have to go through the full licensing procedure if they wish to obtain 
injectable morphine.149 
 
 
                                                          
146 Human Rights Watch email correspondence with Dr. Anil Paleri, secretary of the Indian Association of Palliative Care, July 
22, 2009. 
147 M.R. Rajagopal, D.E. Joranson, and A.M. Gilson, “Medical Use, Misuse, and Diversion of Opioids in India,” The Lancet , vol. 
358 (2001), pp. 139-143.  
148 Human Rights Watch interview with M.P. George, Kerala state drugs controller, Trivandrum, Kerala, March 17, 2009. 
149Human Rights Watch interview with Dr. M.R. Rajagopal, March 17, 2008. 
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Map 2: States and Union Territories that have adopted the model rule 
 
© 2009 John Emerson 
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The International Narcotics Control Board and poor morphine availability 
The INCB, an independent and quasi-judicial international body, has a mandate to monitor 
the implementation of the 1961 Single Convention on Narcotic Drugs and other international 
drug conventions. This mandate requires it to monitor efforts of governments to implement 
provisions of the conventions related to the prevention of illicit use of controlled 
substances, as well as efforts to ensure their adequate availability for medical and scientific 
purposes. However, in the past 10 years there has been a clear imbalance in INCB’s 
monitoring of these two aspects of its mandate with respect to India. In its last six annual 
reports, it has made no mention at all of the poor availability of morphine for pain treatment 
in India. In the two years before that, it complimented India on the introduction of the model 
rule.150 While in 2002 and 2003 the INCB noted that India had failed to submit statistics on 
morphine consumption, it has not done so since.151 At the same time, INCB’s annual reports 
make routine and extensive mention of India’s drug control efforts. In a September 2009 
letter to Human Rights Watch, the secretary of INCB stated that “in addition to its annual 
report, the Board uses many other avenues to pursue a continuous dialogue with 
Governments on various issues, including the availability of internationally controlled 
substances for medical purposes.”152 
                                                          
150 INCB, Report of the INCB for 2001, E/INCB/2001/1, http://www.incb.org/incb/en/annual_report_2001.html (accessed 
August 3, 2009), para. 198; and Report of the INCB for 2002, E/INCB/2002/1, 
http://www.incb.org/incb/en/annual_report_2002.html (accessed August 3, 2009), para. 168.  
151 Ibid. India did not report consumption statistics for morphine for the years 2002 to 2006. It has reported consumption 
figures for 2007, the latest year for which INCB has made data available to date.  
152 Letter dated September 28, 2009 from Koli Kouame, secretary of the INCB. On file with Human Rights Watch. 
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The Human Rights Analysis 
 
National Law 
The Indian constitution does not recognize a right to health per se but there is a growing 
body of jurisprudence from the constitutional courts of India (Supreme Court and High 
Courts) that recognizes the right to health as a fundamental right, albeit derivatively, under 
the right to life.153  
 
The Supreme Court has held that the right to life imposes a positive obligation on the part of 
the state to safeguard the life of every person, stating that the “preservation of human life 
[is] of utmost importance” and that 
 
[t]he Constitution envisages the establishment of a welfare state ... Providing 
adequate medical facilities for the people is an essential part of the 
obligations undertaken by the government in this respect [and it] discharges 
this obligation by running hospitals and health centres.154 
 
Many economic and social rights are included in the Directive Principles of State Policy 
section of India’s constitution. Article 47, which comes under this section, stipulates 
improvement of public health as among the state’s primary duties. According to article 37 of 
the constitution, the directive principles “shall not be enforceable by any court, but ... are 
nevertheless fundamental in the governance of the country and it shall be the duty of the 
state to apply these principles in making laws.”155 In fact, the Supreme Court has used article 
47 to strengthen its jurisprudence on the right to health. 
 
While these rulings refer to curative rather than palliative care, in a groundbreaking case in 
1998 the Delhi High Court held that patients suffering from moderate and severe pain have a 
                                                          
153 The Supreme Court and High Courts have held that the right to health is a fundamental right in CESC Ltd. vs. Subhash 
Chandra Bose, (AIR 1992 SC 573, 585); that everyone is entitled to adequate health care in Mahendra Pratap Singh vs. Orissa 
State (AIR 1997 Ori 37); that health and healthcare of workers is an essential component of right to life in CERC v. Union of 
India, (1995) 3 SCC 42 and Kirloskar Brothers Ltd. v. Employees’ State Insurance Corporation, (1996) 2 SCC 682, and in State 
of Punjab and others v. Mohinder Singh Chawla and Ors 1997 (2) SCC 83; that the right to healthcare of government 
employees is integral to right to life in State of Punjab vs. Mohinder Singh Chawla 1997 2 SCC 83; and that emergency 
healthcare is essential to the right to life in Paschim Banga Khet Mazdoor Samiti vs. State of W .B. (1996) 4 SCC 37. 
154 Ibid. For a more detailed description see Iain Byrne, “Enforcing the Right to Health: Innovative Lessons from Domestic 
Court,” in Andrew Clapham and Mary Robinson, eds., Realizing the Right to Health (Zurich: Rüffer & Rub, 2009), 
http://www.swisshumanrightsbook.com/SHRB/shrb_03_files/37_453_Byrne.pdf (accessed July 28, 2009), pp. 525-557. 
155 Constitution of India, arts. 37 and 47. 
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right to adequate medications, including morphine. The case concerned a woman who 
required morphine for severe cancer-related pain but was not able to obtain any because of 
complex narcotics regulations. In his petition, the woman’s son asked the court to direct 
concerned government agencies to adopt rational narcotics regulations that ensure 
availability of morphine for medical purposes. The court expressed dismay at the delays and 
obstacles the plaintiff’s mother had faced in accessing morphine, stating that “any official 
standing in the way will be viewed very seriously by the court.”156 The court directed 
government agencies to adopt “rational” rules and ensure availability of morphine. As the 
government has failed to adequately implement the ruling, the plaintiff has since filed a 
similar case with India’s Supreme Court.157 
 
The Right to Health 
Health is a fundamental human right enshrined in numerous international human rights 
instruments. The International Covenant on Economic, Social and Cultural Rights specifies 
that everyone has a right “to the enjoyment of the highest attainable standard of physical 
and mental health.”158 The Committee on Economic, Social and Cultural Rights, the body 
charged with monitoring compliance with the ICESCR, has held that states must make 
available in sufficient quantity “functioning public health and health-care facilities, goods 
and services, as well as programmes,” and that these services must be accessible. 
 
Because states have different levels of resources, international law does not mandate the 
kind of healthcare to be provided. The right to health is considered a right of “progressive 
realization.” By becoming party to the international agreements, a state agrees “to take 
steps ... to the maximum of its available resources” to achieve the full realization of the right 
to health. In other words, high-income countries will generally have to provide healthcare 
services at a higher level than those with limited resources. But any country will be expected 
to take concrete and reasonable steps toward increased services, and regression, in most 
cases, will constitute a violation of the right to health. 
 
However, the Committee on Economic, Social and Cultural Rights has held that there are 
certain core obligations that are so fundamental that states must fulfill them. While resource 
constraints may justify only partial fulfillment of some aspects of the right to health, the 
Committee has observed with respect to the core obligations that “a State party cannot, 
under any circumstances whatsoever, justify its non-compliance with the core obligations..., 
                                                          
156 All India Lawyers’Forum for Civil Liberties v. Union of India, (1998), WP 942/98.  
157 The case documents are on file with Human Rights Watch. 
158 ICESCR, art. 12. 
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which are non-derogable.” The Committee has identified, among others, the following core 
obligations: 
 
• To ensure the right of access to health facilities, goods, and services on a non-
discriminatory basis, especially for vulnerable or marginalized groups; 
• To provide essential drugs, as from time to time defined under the WHO Action 
Programme on Essential Drugs;  
• To ensure equitable distribution of all health facilities, goods, and services; and 
• To adopt and implement a national public health strategy and plan of action, on the 
basis of epidemiological evidence, addressing the health concerns of the whole 
population.159 
 
As noted in the previous chapter, the Committee lists the obligation to provide appropriate 
training for health personnel as an “obligation of comparable priority.” 
 
Palliative Care and the Right to Health 
Given that palliative care is an essential part of healthcare, the right to health requires that 
countries take steps to the maximum of their available resources to ensure that it is 
available. Indeed, the Committee on Economic, Social and Cultural Rights has called for 
“attention and care for chronically and terminally ill persons, sparing them avoidable pain 
and enabling them to die with dignity.”160 A number of different state obligations flow from 
this: 
 
• A negative obligation to refrain from enacting policies or undertaking actions that 
arbitrarily interfere with the provision or development of palliative care; 
• A positive obligation to take reasonable steps to facilitate the development of 
palliative care; and 
• A positive obligation to take reasonable steps to ensure the integration of palliative 
care into existing health services, both public and private, through the use of 
regulatory and other powers as well as funding streams. 
 
 
 
                                                          
159 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14. 
160 Ibid., para 25. While the Committee included this reference in a paragraph on the right to health for older persons, the 
wording clearly indicates that it applies to all chronically and terminally ill persons.  
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No interference with palliative care 
The Committee on Economic, Social, and Cultural Rights has stipulated that the right to 
health requires states to “refrain from interfering directly or indirectly with the enjoyment of 
the right to health.”161 States may not deny or limit equal access for all persons, enforce 
discriminatory health policies, arbitrarily impede existing health services, or limit access to 
information about health.162 Applied to palliative care, this obligation means that states may 
not put in place drug control regulations that unnecessarily impede the availability and 
accessibility of essential palliative care medications such as morphine and other opioid 
analgesics. 
 
Facilitating the development of palliative care 
The right to health also includes an obligation to take positive measures that “enable and 
assist individuals and communities to enjoy the right to health.”163 Applied to palliative care, 
this means that states must take reasonable steps in each of the three areas the World 
Health Organization has identified as essential to the development of palliative care.164 As 
noted in chapter IV, the three prongs of the WHO recommendation on palliative care 
development correspond closely with several of the core obligations under the right to 
health. This means that states cannot claim insufficient resources as justification for failing 
to take steps in each of these three areas.165 
 
Ensuring integration of palliative care into health services 
The right to health requires states to take the steps necessary for the “creation of conditions 
which would assure to all medical service and medical attention in the event of sickness” 
(emphasis added).166 The Committee on Economic, Social and Cultural Rights has held that 
people are entitled to a “system of health protection which provides equality of opportunity 
for people to enjoy the highest attainable level of health.”167 In other words, health services 
should be available for all health conditions, including chronic or terminal illness, on an 
equitable basis.  
 
                                                          
161 Ibid., para. 33. 
162 Ibid., para. 33. 
163 Ibid., para. 37. 
164 WHO, Cancer Pain Relief Second Edition, With a Guide to Opioid Availability (Geneva: WHO Press, 1996), p. 3. 
165 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14, para 47. 
166 ICESCR, art. 12 (2). 
167 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14, para 8. 
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The Committee has called for an integrated approach to the provision of different types of 
health services that includes elements of “preventive, curative and rehabilitative health 
treatment.”168 It has also held that 
 
investments should not disproportionately favour expensive curative health 
services which are often accessible only to a small, privileged fraction of the 
population, rather than primary and preventive health care benefiting a far 
larger part of the population.169  
 
While the Committee does not explicitly say so, the same principle applies to palliative care 
services. 
 
Given the large percentage of cancer patients who require palliative care services, 
particularly in low- and middle-income countries, considerable urgency needs to be given to 
developing palliative care services for cancer patients. 
 
Considering WHO’s recommendation that low- and middle-income countries focus on 
developing community-based palliative care services because they are inexpensive, such 
countries should take active steps to ensure their development. 
 
The Prohibition of Cruel, Inhuman, and Degrading Treatment 
The right to be free of cruel, inhuman, and degrading treatment is a fundamental human 
right that is recognized in numerous international and regional human rights instruments.170 
Apart from prohibiting the use of torture and other cruel, inhuman, or degrading treatment or 
                                                          
168 Ibid., para. 25. 
169 Ibid., para. 19. 
170 International Covenant on Civil and Political Rights (ICCPR), adopted December 16, 1966, G.A. Res. 2200A (XXI), 21 U.N. 
GAOR Supp. (No. 16) at 52, U.N. Doc. A/6316 (1966), 999 U.N.T.S. 171, entered into force March 23, 1976. Article 7 provides, 
“No one shall be subjected to torture or to cruel, inhuman or degrading treatment or punishment.” See also Universal 
Declaration of Human Rights (UDHR), adopted December 10, 1948, G.A. Res. 217A(III), U.N. Doc. A/810 at 71 (1948); Convention 
against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment (Convention against Torture), adopted 
December 10, 1984, G.A. res. 39/46, annex, 39 U.N. GAOR Supp. (No. 51) at 197, U.N. Doc. A/39/51 (1984), entered into force 
June 26, 1987; Inter-American Convention to Prevent and Punish Torture, O.A.S. Treaty Series No. 67, entered into force 
February 28, 1987; European Convention for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment 
(ECPT), signed November 26, 1987, E.T.S. 126, entered into force February 1, 1989; African [Banjul] Charter on Human and 
Peoples’ Rights, adopted June 27, 1981, OAU Doc. CAB/LEG/67/3 rev. 5, 21 I.L.M. 58 (1982), entered into force October 21, 
1986. 
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punishment, the right also creates a positive obligation for states to protect persons in their 
jurisdiction from such treatment.171 
 
As part of this positive obligation, states have to take steps to protect people from 
unnecessary pain related to a health condition. As UN Special Rapporteur on Torture and 
other Cruel, Inhuman or Degrading Treatment or Punishment Manfred Nowak wrote in a joint 
letter with UN Special Rapporteur on the Right to Health Anand Grover to the Commission on 
Narcotic Drugs in December 2008, 
 
Governments also have an obligation to take measures to protect people under 
their jurisdiction from inhuman and degrading treatment. Failure of governments 
to take reasonable measures to ensure accessibility of pain treatment, which 
leaves millions of people to suffer needlessly from severe and often prolonged 
pain, raises questions whether they have adequately discharged this 
obligation.172 
 
In a report to the Human Rights Council, Nowak later specified that, in his expert opinion, 
“the de facto denial of access to pain relief, if it causes severe pain and suffering, 
constitutes cruel, inhuman or degrading treatment or punishment.”173 
 
Not every case where a person suffers from severe pain but has no access to appropriate 
treatment will constitute cruel, inhuman, or degrading treatment or punishment. Human 
Rights Watch believes that this will only be the case when the following conditions are met: 
 
• The suffering is severe and meets the minimum threshold required under the 
prohibition against torture and cruel, inhuman, or degrading treatment or 
punishment; 
• The state is, or should be, aware of the level and extent of the suffering; 
                                                          
171 UN Human Rights Committee, General Comment 20, para. 8, 
http://www.unhchr.ch/tbs/doc.nsf/(Symbol)/6924291970754969c12563ed004c8ae5?Opendocument (accessed August 29, 
2009). See also the judgment of the European Court of Human Rights in Z v United Kingdom (2001) 34 EHHR 97. 
172 Joint letter by the UN special rapporteur on the prevention of torture and cruel, inhuman or degrading treatment or 
punishment, Manfred Nowak, and the UN special rapporteur on the right of everyone to the enjoyment of the highest 
attainable standard of physical and mental health, Anand Grover, to the Commission on Narcotic Drugs, December 2008. A 
copy of the letter is available at http://www.ihra.net/Assets/1384/1/SpecialRapporteursLettertoCND012009.pdf (accessed 
January 16, 2009). 
173 Human Rights Council, Report of the Special Rapporteur on torture and other cruel, inhuman or degrading treatment or 
punishment, Manfred Nowak, A/HRC/10/44, January 14, 2009, 
http://daccessdds.un.org/doc/UNDOC/GEN/G09/103/12/PDF/G0910312.pdf?OpenElement (accessed August 4, 2009), para. 
72.  
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• Treatment is available to remove or lessen the suffering but no appropriate treatment 
was offered; and 
• The state has no reasonable justification for the lack of availability and accessibility 
of pain treatment. 
 
In such cases, states will be liable for failing to protect a person from cruel, inhuman, or 
degrading treatment. 
 
Failure to ensure pain treatment at India’s regional cancer centers—A form of cruel, 
inhuman and degrading treatment 
The majority of patients at India’s regional cancer centers requires palliative care and 
suffers from moderate to severe pain. Human Rights Watch believes that the India 
government, while investing considerable funds into regional cancer centers, has failed to 
take reasonable measures to address their lack of palliative care availability. The 
government has at its disposal various ways to ensure that regional cancer centers offer 
palliative care and pain treatment—it could have specifically earmarked funds for palliative 
care or made the designation of “regional cancer center” conditional on the development 
of palliative care—but it has chosen not to use them. As of July 2009, more than half of 
India’s regional cancer centers did not have such services.  
As demonstrated in chapter III, the failure to ensure availability of such treatment leaves 
many patients to needlessly suffer excruciating pain, which may persist over extended 
periods of time, often without any respite at any time of the day. The kind of suffering these 
patients endure is so serious that it meets the minimum threshold for government liability 
under the prohibition of cruel, inhuman and degrading treatment. 
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A Way Forward 
 
The introduction of palliative care throughout India at tertiary, secondary, and primary health 
facilities as well as in the community is urgently needed to prevent the gross and 
unnecessary suffering of millions of people throughout the country. The Indian government, 
as a signatory to various international human rights treaties, must play an important role in 
making this happen. Yet, to date, the central and state governments have, by and large, 
abdicated this duty, leaving it to nongovernmental organizations and individual healthcare 
workers to develop these health services. 
 
To move palliative care services forward—and to live up to its obligations under international 
law—the Indian authorities, at both central and state levels, need to urgently formulate and 
implement a plan of action for developing palliative care services and overcoming the 
various policy, regulatory, and educational barriers described in this report. 
 
In doing so, the authorities in India have the enormous benefit of being able to draw on local 
solutions. India is blessed with a considerable number of extremely knowledgeable and 
committed palliative care specialists who have been grappling with these barriers for more 
than a decade. There are best practice examples at various levels, for community-based and 
institution-based palliative care. A model for regulatory reform already exists. Five medical 
colleges are already teaching palliative care as part of undergraduate medical education, 
and a number of teaching hospitals have developed models for palliative care and pain 
management instruction at the postgraduate level. 
 
But as long as the central and state governments fail to assume their role in developing 
palliative care services, progress will continue to be marginal in most places.  
 
Refraining from Interference with and Facilitating Development of Palliative Care  
At present, the Indian government and state governments violate the obligation to refrain 
from taking actions and enforcing policies that interfere with palliative care, and the 
obligation to take steps to facilitate its development. This situation can be remedied by 
taking the following steps: 
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On policy development 
In order to comply with the right to health, the Indian government and state governments 
need to put in place relevant policies or strategic plans for the development of palliative care 
and to incorporate a meaningful palliative care component in the national cancer and AIDS 
control programs. Human Rights Watch recommends the following steps on policy 
development: 
• The Indian government should convene an inclusive meeting of all relevant 
stakeholders, including the Ministry of Health and Family Welfare, the drugs 
controller general, the Department of Revenue, the Medical Council of India, the 
narcotics commissioner, the Indian Association of Palliative Care, the Institute of 
Palliative Medicine, Pallium India, and other leading palliative care groups, to 
develop a national palliative care policy and a strategy for its implementation. The 
policy and strategy should address all existing barriers to the development of 
palliative care, including policy, regulatory, educational, and other obstacles. It 
should set clearly defined benchmarks and timelines for overcoming these barriers 
and introducing palliative care in both institutional and community settings. It 
should set up a system for periodic review of progress and adjustments of 
benchmarks, as necessary. 
• The Ministry of Health and Family Welfare should implement, to the extent possible, 
the recommendations made by the palliative care taskforce. If certain aspects of the 
recommendations are not carried out, it should publicly explain the rationale for 
such decisions. 
• As part of its efforts to develop palliative care services at ART and community care 
centers, the National AIDS Control Organization should develop clear benchmarks 
and timelines for providing these services, including by incorporating instruction for 
healthcare workers on palliative care and ensuring availability of opioids at 
community care centers and ART centers. 
• State governments should organize stakeholder meetings with the health 
department, drugs controller, excise department, directorate of medical education, 
healthcare providers, and palliative care specialists to develop plans of action, with 
concrete benchmarks and timelines, for the development of community-based 
palliative care services. Drawing on the experiences of Kerala and other states, these 
stakeholder meetings should, among others, lead to: 
o Development, adoption, and enactment of state palliative care policies; 
o An assessment of the need for palliative care and the barriers to its 
development; 
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o Identification of funding for development of palliative care services in the 
community; 
o Development of a plan for the gradual incorporation of palliative care 
instruction into undergraduate and relevant postgraduate curricula for 
healthcare professionals; and  
o Introduction of the model rule for opioid availability, if not already adopted, 
with clear operating procedures to ensure smooth implementation. 
 
On education 
The Indian government and state governments need to set a clear standard for education in 
palliative care to ensure that healthcare providers—first and foremost those who see large 
numbers of patients in need of palliative care—have at least basic training in the discipline. 
Human Rights Watch makes the following recommendations on ensuring adequate 
education for healthcare workers: 
• The Ministry of Health and Family Welfare, the Medical Council of India, state 
directorates of medical education, representatives of medical colleges, and palliative 
care providers should jointly develop a plan of action for the gradual introduction of 
palliative care instruction into curricula for medical and nursing education.  
• Until this has happened, the Medical Council of India should specifically encourage 
medical colleges to integrate basic instruction on palliative care into the existing 
curriculum, as a number of medical colleges have already done. 
• The Medical Council of India should include palliative care as a topic in exams for 
medical licenses. 
• The Medical Council of India should mandate rotations in palliative care units for 
students of certain postgraduate programs, including oncology, to ensure clinical 
exposure to palliative care.  
• The Ministry of Health and Family Welfare should develop nodal palliative care 
training centers in each of India’s five geographical regional zones, as recommended 
by the palliative care taskforce. 
• The Ministry of Health and Family Welfare should develop training modules for 
doctors, nurses, social workers, counselors, and volunteers, in cooperation with the 
Indian Association of Palliative Care, the Institute of Palliative Medicine, Pallium 
India, and other relevant palliative care groups. 
• The National AIDS Control Organization should incorporate palliative care instruction 
into its training courses for HIV/AIDS healthcare workers. 
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On drug availability 
To comply with its obligations under international human rights law, India must take 
immediate steps to ensure an effective supply and distribution system of opioid 
medications; avoid excessively strict drug control regulations that interfere with opioid 
availability; and prevent fear of legal sanction among healthcare workers. Human Rights 
Watch makes the following recommendation: 
• State governments that have not yet done so should immediately implement the 
model rule as proposed by the Department of Revenue. The role of the excise 
department, which has no expertise on medical or healthcare issues, in the licensing 
of healthcare providers for opioid medications should be eliminated all over India. 
• The Department of Revenue should issue a clarification to state governments that 
the model rule applies to all formulations of morphine, not just oral morphine. Drugs 
controllers who currently limit the application of the model rule to oral morphine 
should allow its application to injectable and liquid morphine as well. 
• The Department of Revenue should recommend the simplification of access to opioid 
medications other than morphine. Availability of and accessibility to these 
medications continues to be severely limited by the cumbersome procedure 
established under the NDPS Act. The role of the excise department should be 
eliminated, the licensing system simplified, and validity periods of licenses 
extended. 
• State governments that have not yet included oral and injectable morphine into their 
lists of essential medicines should take steps to do so, as recommended both by 
India’s central government and the World Health Organization. 
• The narcotics commissioner and Narcotics Control Bureau should ensure that India 
reports on morphine consumption annually, as required by the 1961 Single 
Convention on Narcotic Drugs. 
 
Fear of legal sanction among healthcare workers 
Human Rights Watch believes that unintentional mistakes in handling opioids should not be 
subject to criminal liability. We therefore recommend that 
• The NDPS Act should be amended or an exception should be introduced to clarify 
that section 26 does not apply to unintentional mistakes by healthcare workers. 
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Ensuring Integration of Palliative Care into Health Services 
As noted above, palliative care remains poorly integrated into cancer and HIV/AIDS care in 
India. To respect its obligations under the right to health, the Indian government needs to 
undertake the following steps: 
• Develop a clear plan for the integration of palliative care into cancer care services 
and provide funding for the implementation of that plan. The April 2006 
recommendations of the taskforce that the Ministry of Health and Family Welfare 
appointed are such a plan. The government should either implement it or, if it deems 
aspects of the recommendations unacceptable, should clarify what these aspects 
are and why, and either revise the plan accordingly itself or ask the taskforce to do 
so. The revised plan should then be implemented as soon as possible. 
• The government should develop a plan for the integration of palliative care services 
into health services for people living with HIV and AIDS, and allocate funds to 
implement that plan. A rational public health approach requires that as countries 
scale up their ART programs they should also scale up palliative care services, 
particularly considering that the cost of providing palliative care is very small 
compared to that of ART programs. 
• The Indian government and state governments should seek to invest additional 
funds into the development of community-based palliative care services, as the 
provision of palliative care in institutional settings is not sufficient to meet the needs 
of patients. Indeed, the World Health Organization recommends the development of 
community-based palliative care as an inexpensive and cost-efficient model that is 
particularly appropriate for low- and middle-income countries. To date, only the 
government of Kerala has made such investments. 
 
Recommendations to the INCB and Donors 
To the International Narcotics Control Board 
• Consistently report in its annual report on the availability of controlled substances 
for medical and scientific purposes in countries, including on specific barriers that 
impede such availability. 
• Plan a fact-finding mission to India, with availability of controlled substances for 
medical and scientific purposes as one area of focus. On such a mission, the INCB 
delegation should meet both with relevant government officials and representatives 
of palliative care organizations, such as the Indian Association of Palliative Care, 
Pallium India, and other leading palliative care groups. 
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• Urge India to submit data on consumption of morphine every year, as required by the 
1961 Single Convention on Narcotic Drugs. 
• Request information from the Indian government about efforts it has made to ensure 
adequate availability of controlled substances for medical and scientific purposes, 
and about remaining barriers. 
• Establish regular contact with key palliative care leaders to ensure the INCB receives 
information on opioid availability barriers directly from healthcare providers. 
 
To international donors 
• Ensure that palliative care and pain management are an integral part of any 
programs that are funded to provide care and treatment services to people living 
with HIV and AIDS. 
• Require that supported healthcare institutions obtain a license for morphine and 
other opioid analgesics and maintain an adequate stock of these medications. 
• Financially support training of healthcare workers at ART centers and community care 
centers on palliative care and pain management. 
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Appendix 1: Morphine Licensing System under Unamended State 
Narcotics Rules 
 
Following the enactment of the 1985 Narcotic Drugs and Psychotropic Substances Act, 
India’s states and territories adopted narcotics regulations that, among others, set out the 
procedure for obtaining access to opioid medications. Although these regulations vary from 
state to state, the procedure they provide for has many similarities across the country.  
 
Procedure for Obtaining a Possession License 
A document prepared under the Collaborative Programme of the Indian government and the 
World Health Organization, entitled “Guidelines for Developing of Palliative Care 
Services,”174 lists the following steps as typically required for obtaining a possession and 
import license under the unamended regulations: 
 
1. Application for license submitted to the local excise office 
2. Inspection of applicant institution by local excise official 
3. Application forwarded to the state excise commissioner 
4. Application forwarded to the state drugs controller 
5. Inspection of the applicant institution by the state drugs inspector 
6. Transmission of approval of drugs inspector to the drugs controller 
7. Application forwarded to health authority for approval 
8. Health authority forwards to relevant official for inspection 
9. Transmission of approval of health authority to drugs inspector 
10. Transmission of approval of drugs controller to excise commissioner 
11. Transmission of approval to local excise office 
12. License issued 
 
Figure 1 gives a visual overview of these various steps. Possession licenses generally have to 
be renewed once per year. 
                                                          
174 MNJ Institute of Oncology and Regional Cancer Centre, “Guidelines for Developing of Palliative Care Services,” 2009. 
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Figure 1: Procuring Oral Morphine in a State without Amended Regulations175 
 
 
                                                          
175 Ibid. 
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Procedure for Obtaining Procurement Licenses 
The procedure for obtaining procurement licenses—such as import and transport licenses—
is similar to that for the possession license. Again, an application needs to be lodged with 
the excise department, which seeks the involvement of the drugs controller and health 
authority. Once more, the application has to be approved at various levels of the 
bureaucracy at both departments. After the excise office issues the import license, the 
medical institution has to take the following steps before it actually receives the morphine: 
1. Order is placed with manufacturer, along with payment 
2. If manufacturer is in another state, it must apply for an export license from the state 
excise office 
3. Excise office issues the export permit to the manufacturer 
4. Drugs are dispatched by registered mail 
5. The applicant institution receives the parcel 
6. Local excise office is informed 
7. Visit by excise official to open parcel in his/her presence176 
 
                                                          
176 Ibid. 
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Annex 1: Model Rule 
 
Special Provisions Relating to the Use of Morphine by Recognized Medical Institutions in 
the Amended State 
1. Notwithstanding any provisions to the contrary in these rules, possession, transport, 
purchase, sale, import inter-state, export inter-state or use of morphine or any 
preparation containing morphine in respect of a recognized medical institution shall 
be as per the following provisions. 
2. Definitions: In this chapter, unless the context otherwise requires: 
i. morphine includes any preparation containing morphine 
ii. “Recognized medical institution” means a hospital or medical institution 
recognized for the purposes under this chapter. It is the responsibility of the 
institution so recognized to ensure that morphine obtained by them is used 
for medical purposes only. 
3. Recognition of medical institutions: 
i. Every medical institution which intends to be recognized for the purpose 
under this chapter shall apply in the format at Annexure 1 (Appendix V) to the 
Drugs Controller appointed by the State Government who shall convey his 
decision within three months of the receipt of the application. 
ii. If it comes to the notice of the Drugs Controller that morphine obtained by a 
recognized institution was supplied for non-medical use or that any of the 
rules under this chapter is not complied with, for reasons to be recorded in 
writing, the Drugs Controller may revoke the recognition accorded under 
these rules. 
4. Duties of a recognized medical institution: 
Every recognized medical institution shall 
i. Designate one or more qualified medical practitioner who may prescribe 
morphine for medical purposes. When more than one qualified medical 
practitioner have been designated, one of them shall be designated as over-
all in-charge: 
ii. The designated medical practitioner or the overall in charge, as the case may 
be, shall  
a. Endeavour to ensure that the stock of morphine is adequate for 
patient needs,  
b. Maintain adequate security over stock of morphine, 
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c. Maintain a record of all receipts and disbursements of morphine in 
the format enclosed as Annexure 2 (Appendix V) and 
d. Ensure that estimates and other relevant information required to be 
sent by the recognized medical institution under this chapter are sent 
to the authorities concerned 
5. Sending of estimates of requirement of morphine by the recognized medical 
institution  
Every recognized medical institution shall send their annual requirement of 
morphine in the format at Annexure III (Appendix V) by 30th November of the 
preceding year along with the name and address of the supplier from whom they 
intend to buy it to the Drugs Controller. 
6. Approval of estimates by the Drugs Controller  
The Drugs Controller who receives the annual requirement shall consider it, and may 
if necessary call for necessary clarification. A reply on approved estimates or not 
accepting the estimates shall be sent before 21st of December of the preceding year. 
A copy of the communication shall be sent each to the supplier whose name has 
been given in the estimate, if the supplier is located in another state, the Drugs 
Controller of that state, the Drugs Controller General of India and the Narcotics 
Commissioner of India 
7. Supplementary estimates 
If the requirement of the recognized medical institution exceeds the annual estimate 
approved by the Drugs Controller, the recognized medical institution may send a 
supplementary estimate at any time to the Drugs Controller which shall be 
considered and dealt with by the Drugs Controller in the same manner as the annual 
estimates. 
8. The provisions of these rules in other chapters in respect of possession, transport, 
sale, import inter-state, export inter-state or use of manufactured drugs shall not 
apply to possession, transport, purchase, sale, import inter-state, export inter-state 
or use of morphine in respect to a recognized medical institution. Possession, 
transport, purchase, sale, import inter-state, export inter-state or use of morphine in 
respect to a recognized medical institution shall be in accordance with the following 
provisions: 
i. The recognized medical institution shall place orders for purchase to a 
manufacturer/supplier in the format at Annexure IV (Appendix V) along with a 
photocopy of the communication of the Drugs Controller vide which the 
institution was recognized for the purpose of this chapter and a copy of the 
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communication of the Drugs Controller vide which the approved estimates 
were conveyed. A copy of the order for purchase shall be sent to the Drugs 
Controller and the Narcotics Commissioner of India.  
ii. Any manufacturer or supplier shall send morphine to the recognized medical 
institution under this chapter only on the basis of an order for purchase 
received in the format of Annexure IV along with copies of recognition 
granted by the Drugs Controller and the approved estimates communicated 
by the Drugs Controller. The manufacturer/supplier shall dispatch the 
morphine consignment note in quintuplicate in the format given in Annexure 
V (Appendix V). Copies of the consignment note shall be sent by the 
manufacturer/supplier to the Drugs Controller of the state in which the 
manufacturer/supplier is located, the Drugs Controller of the state in which 
the recognized medical institution is located and the Narcotics 
Commissioner of India. He shall also keep a copy of the consignment note. 
iii. On receipt of the consignment, the medical institution shall enter the 
quantity received with date in all the copies of the consignment note, retain 
the original consignment note, send the duplicate to the supplier, triplicate 
to the Drugs Controller, the quadruplicate to the Drugs Controller of the State 
(in cases in which the consignment originated outside the State) in which the 
supplier is located and the quintuplicate to the Narcotics Commissioner of 
India. 
9. Maintenance of records 
All records generated under this chapter shall be kept for a period of two years from 
the date of transaction. They shall be open for inspection by the officers empowered 
by the State Govt. under Sections 41 and 42 of the Narcotic Drugs and Psychotropic 
Substances Act 1985. 
10. Inspection of stocks of morphine 
The stocks of morphine under the custody of a recognized medical institution shall 
be open for inspection by the Drugs Controller or any other officer subordinate to him 
or the officers of other departments of the State Goverment empowered under 
Section 41 and 42 of the Narcotic Drugs and Psychotropic Substances Act 1985.  
11. Appeals 
Any institution aggrieved by any decision or orders passed by the Drugs Controller 
elating to recognition, revocation of recognition of any institution or estimates, can 
appeal to the Secretary, Department of Health of the State Govt. within 90 days from 
the date of communication of such decision or order. 
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 Annex 2: Palliative Care Taskforce Recommendation177 
 
Strategy for palliative care:  
National Cancer Control Program  
11th five year plan – 2007- 2012 
Palliative care and Rehabilitation committee 
Co-ordinator:  Dr M.R.Rajagopal, Chairman, Pallium India. 
Members:  
1. Dr Dinesh Goswami, Guwahati   
2. Ms Kumari Thankam, RCC, Tvm 
3. Dr. Firuza Patel, PGIMER, Chandigarh 
4. Dr Gayatri Palat, AIMS, Kochi   
5. Ms Harmala Gupta, Cansupport, Delhi   
6. Dr. Maryanne Muckadan, TMH, Mumbai  
7. Ms Poonam Bagai,Cankids, Delhi   
8. Dr Prabha Chandra, NIMHANS, Bangalore  
9. Dr Reena Mary George, CMC, Vellore 
10. Dr Sushama Bhatnagar, AIIMS, New Delhi  
11. Dr. Sureshkumar, Calicut, Kerala    
12. Dr. Vijaya, RCC, Trivandrum     
 
Address for correspondence: [Omitted] 
 
EXECUTIVE SUMMARY 
 
1. Current Status and Need:  
? In the year 2004, over 20 lakhs Indians had cancer.  
? More than 80% (16 lakhs) of them were incurable at the time of diagnosis, and needed 
palliative care.  
? By year 2015, it is projected that the total prevalence of cancer in the country would be 
25 lakhs. 
? By 2015, even if the mortality rate were to come down to the international standard of 
50%, 12.5 lakh Indians would still need palliative care. 
? All patients need supportive care during treatment. 
                                                          
177 This is an extract: Full document, including appendices is reproduced at http://www.hrw.org/en/node/85921. 
 
Unbearable Pain     76 
? Palliative care is mentioned as pain relief and terminal care in NCCP; but not practiced as 
an integral part of cancer care in most RCCs and oncology wings. 
? Oral morphine, the most important medication for relief of cancer pain, is not available to 
more than 99% of patients. 
? There are very few doctors and nurses in the country with any palliative care education. 
 
2. What is palliative care, and what is supportive care? 
Palliative care attempts to improve quality of life of patients and families through assessment and 
management of factors reducing quality of life, like pain and other symptoms, as well as psycho-
socio-spiritual problems. Most of those undergoing curative treatment need supportive care – 
application of principles of palliative care – reducing suffering and improving compliance to 
treatment.  
 
3. Common barriers to access to palliative care that have been identified are: 
3.1. Lack of palliative care services in most of the country. 
3.2. Lack of awareness among professionals, administrators and the public. 
3.3. Lack of facilities for palliative care education in the country. 
3.4. Unrealistic narcotic regulations preventing access to opioids for those in pain. 
3.5. Lack of clear guidelines for those wishing to provide palliative care services. 
 
4. WHO recommendation for palliative care development: The World Health Organization 
(WHO) recommends that, to be effective, any palliative care policy has to address all three 
sides of the following triangle with the State Policy at the base, their broad objective being to 
improve access to palliative care to all those who need it. 
 
5. Broad objectives: To develop 
A. Strategy for formulation of Palliative Care Policy, including involvement of non-
governmental organizations  
Drug 
availability 
Education 
Policy
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B. Strategy for development of Palliative Care Delivery services including manpower 
C. Strategy for improved, safe, availability of opioids for pain relief  
D. Strategy for Palliative Care Education and Training of professionals and others 
including volunteers. 
E. Strategy for Advocacy, Awareness Building and Community Participation  
  
 
6. POLICY: 
6.1. Objective:  
6.1.1. Declaration by NCCP that palliative and supportive care should be essential 
parts of cancer care.  
6.1.2. Declaration by all states & UTs that palliative and supportive care should be 
essential parts of cancer care.  
6.2.  Strategy 
6.2.1. Include ‘provision of palliative and supportive care with community participation’ 
as a separate objective of the revised NCCP 
6.2.2. Inclusion of a palliative care provision in the Health Policy of State Governments 
6.3. Coverage: Health policy of centre and 50% of states/UTs 
6.4. Timeline:   
6.4.1. Inclusion in NCCP before 11th FYP 
6.4.2. Inclusion in State Policy – over first 2 years of FYP 
6.5. Budgetary requirement:  Nil 
 
 
7. DEVELOPMENT OF PALLIATIVE CARE SERVICES: 
7.1. Objective: 
7.1.1. Integrate Palliative Care into cancer care in all RCCs and 100 other cancer 
treatment facilities in the country 
7.1.2. Strategy: 
7.1.2.1. RCC Scheme: Starting palliative care service in all Regional cancer centers  
7.1.2.2. Out-of-RCC Scheme: Starting palliative care services in 100 other 
institutions (DCCP/Oncology Wings of Medical Colleges/NGOs) 
7.1.2.3.  Coverage: 25 RCCs and 100 other institutions in the country. 
7.1.2.4. Timeline:  
7.1.2.4.1. Year 1: 5 RCCs and 10 other Cancer treatment centres 
7.1.2.4.2. Year 2: 5 RCCs and 25 other Cancer treatment centres 
Unbearable Pain     78 
7.1.2.4.3. Year 3: 5 RCCs and 25 other Cancer treatment centres 
7.1.2.4.4. Year 4: 5 RCcs and 25 other Cancer treatment centres 
7.1.2.4.5. Year 5: 5 RCCs and 15 other Cancer treatment centres 
7.1.2.5. Budget:  
7.1.2.5.1. RCC Scheme:   Rs 8.625 crores and  
7.1.2.5.2. Out of RCC Scheme:  Rs 32.828 crores 
 
8. OPIOID AVAILABILITY 
8.1.  Objective: 
8.1.1. Ensuring simplified narcotic regulations in all states and union territories of India 
with realistic standard operating procedures. 
8.1.2. Ensuring uninterrupted availability of oral morphine in all regional cancer centers 
and in all hospitals where palliative care facilities have been started. 
8.2. Strategy: 
8.2.1. Opioid Availability Workshops: Up to 3 workshops in 5 years by each RCC 
involving palliative care professionals, NGOs and officials from concerned 
Departments in the State, and of the adjoining State/UT where there is no RCC. 
8.2.2. NGOs in the field are already involved in this work to a limited extent. This task 
force can find a team of facilitators, who can be available to extend expert help at 
these workshops. 
8.3. Coverage: All States and Union Territories 
8.4. Timeline: 3 workshops each year for every year of FYP in every RCC. 
8.5. Budget: Rs 1.125 crores 
 
9. PALLIATIVE CARE EDUCATION AND TRAINING:  
9.1. Objectives: 
9.1.1. Develop training modules for 
9.1.1.1. Doctors 
9.1.1.2. Nurses 
9.1.1.3. Social workers/counselors 
9.1.1.4. Volunteers 
9.1.2. Provide palliative care education to professionals and volunteers. 
9.1.3. Ensure effective training in palliative care at least in all oncology post graduate 
programs including practical exposure and inclusion in the examination process. 
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9.1.4. Develop tools and methods for Qualitative Assessment of Palliative care 
Services 
9.1.5. Development of at least one nodal palliative care training center in five 
geographical regional zones – North, Northeast, West, East and South of India. 
 
9.2.  Strategy: 
9.2.1. Training For palliative care doctors and nurses of 25 RCCs and 100 Out-of-RCC 
Centres (budget provided in RCC and Out of RCC Scheme in item 7) 
9.2.2. Sensitisation in Palliative Care for rest of the staff of 25 RCCs and 100 Out-of-
RCC Centres (budget provided in RCC and Out of RCC Scheme in item 7) 
9.2.3. 12 Working Group Meetings, each with 6 faculty members for development of 
training modules for Palliative Care for Professionals and Undergraduates, and for 
training for Social Workers/Counsellors (to be done over 3 years) 
9.2.4. 6 Working Group Meetings for developing tools and methods for Qualitative 
Assessment of Palliative Care Services rendered to be done over 3 years 
9.2.5. One month rotation in palliative care for oncology postgraduate residents in 
RCCs/Palliative Care Centres/Regional Training Centres. 
9.2.6. Upgradation of one each palliative care centre in five geographical zones in India 
to Regional Training Centres 
9.3.  Coverage: 
9.3.1. All States and UTs, 25 RCCs and 100 Cancer Treatment Centres 
9.4. Timeline: As given in spreadsheet attached. 
9.5. Budget: 
9.5.1. Training and Sensitization provided in RCC and Out of RCC Schemes 
9.5.2. Development of teaching modules: Rs. 0.12 crores 
9.5.3. Development of Quality Assessment Tools: Rs 0.06crores 
9.5.4. Development of Regional Training Centres: Rs 2.8 crores 
 
10. PATIENT ADVOCACY & AWARENESS BY NGOS/INSTITUTIONS 
10.1. Objective: 
10.1.1. Development of Peer Support Groups for cancer Patients and Families 
10.1.2. Promotion of public awareness and promotion of community and NGO 
participation in palliative care 
10.2. Strategy: 
10.2.1. Hold 4 Peer Support Meetings per year in all 125 Palliative Care Centres 
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10.2.2. 600 Palliative Care Awareness Programs by NGOs/Institutions  
10.3. Coverage: All States and UTs,  
10.4. Timeline: Over 5 years  
10.5. Budget:  
10.5.1. For Peer Support Meetings: provided in RCC and Out of RCC Scheme in item 7. 
10.5.2. Budget for 600 Awareness Programs Rs 0.48 crores 
Note: 
? More specific timelines and outcome measures are attached in spreadsheet 
? More detailed strategy for each of the above schemes follows. 
 
SCHEME 1: RCC SCHEME 
 
Starting fully functional palliative care service in all Regional cancer centers (or strengthening 
them where they exist), which should have the following: 
 
? Full-time personnel: One doctor, one nurse and one social worker 
? Essential drugs including morphine available free for poor patients (appendix 1) 
? Inpatient facilities available for palliative care 
? Palliative care training available in the form of two days sensitization course as a CME – 
every six months to majority of doctors, nurses, social workers and volunteers (appendix 
2,3,4 &5) 
? All oncology residents rotated through the palliative care program for one month and 
nursing students for at least one week each 
? Involvement of at least one NGO for palliative care delivery 
? One functional home visit program 
 
Coverage: All 25 RCCs in FYP 
Timeline: 5 RCCs each year over 5 years of FYP 
 
Budget:  
Scheme 
1 
RCC Scheme per month per 
annum 
FYP in 
Rs 
FYP in 
Cr 
      
1.a Staff     
 I full time doctor+nurse + social 
worker 
50000 600000   
1.b Drugs(as per Essentail Drug List) for 
poor patients 
 200000   
1c Training     
 For Staff in Palliative care  100000   
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 For sensitisation for rest of the staff  50000   
 Total Training  150000   
1d Homecare(RCCs Contribution to 
Homecare Service, bal from NGO) 
 200000   
 Total Per RCC  1150000   
Scheme 
1 
Total For 25 RCCs over FYP   86250000 8.625 
 
OUTCOME MEASURES 
? Number of patients seen in palliative care unit 
? Number of personnel being trained including percentage of RCC staff 
? Amount of morphine consumed 
? Number of NGOs involved 
? Quality Assurance measures incorporated (as developed by Working Group by end Year 
3 of FYP) 
 
Appendix 
1. Essential drug list 
2. Volunteer’s –training module 
3. Module for sensitization course 
 
SCHEME 2: OUT OF RCC SCHEME 
 
Starting palliative care programs in oncology departments in Medical Colleges/other hospitals or 
by non government agencies, with community participation: (institutions willing to take this up are 
to be asked to apply for support under this scheme; 100 centers are to be selected; 1-5 per state 
and one per union territory). Each of these should have the following: 
 
Full time or part-time personnel: One doctor, one nurse and one social worker 
Essential drugs including morphine available free for poor patients (appendix 1) 
Inpatient facilities available for palliative care 
Palliative care training available in the form of two days sensitization course as a CME – every six 
months - to majority of doctors, nurses, social workers and volunteers (appendix 2,3,4 &5) 
All residents, nurses and trainees rotated through the palliative care program, where applicable 
Involvement of at least one NGO for palliative care delivery 
One functional home visit program 
Quality assurance measures incorporated 
 
Coverage: 100 Cancer Treatment Centres in the Country 
Timeline: 10 Centres in Year 1, 25 each in Years 2, 3 and 4, and 15 in Year 5 = Total 100 
Budget:  
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Scheme 
2 
100 Other Palliative Care Centres 
-PCCs (DCCP/Oncology Wings of 
Medical Colleges/NGOs) 
per month per 
annum 
FYP in Rs FYP in 
Cr 
2a Staff     
 I part time doctor +nurse+social 
worker 
50000 600000   
2.b Drugs(as per Essentail Drug List)  200000   
2c Training Courses for Drs and 
Nurses in Centre 
 100000   
2d Peer Support Meetings 4 per 
year@8000 
 32000   
2e Homecare(PCCs Contribution to 
Homecare Service, bal from NGO) 
 200000   
 Total Per Palliative Care Centre  1132000   
Scheme 
2 
Total For 100 Centres in Country   328280000 32.828 
 
 
 
OUTCOME MEASURES 
? Number of patients seen in palliative care unit 
? Number of personnel being trained including percentage of RCC staff 
? Amount of morphine consumed 
? Number of home visits 
? Number of NGOs involved 
? Number of volunteers involved in palliative care 
? Quality assurance measures incorporated Services (as developed by Working Group by 
end Year 3 of FYP) 
  
Scheme 3: OPIOID AVAILABILITY WORKSHOPS 
 
All palliative care centers must have morphine. An updated document on procurement of oral 
morphine will be developed with assistance from NGOs and provided to all palliative care centers. 
This is to help hospitals and centers to procure oral morphine in a more effective way. Guidelines 
will be made for states with and without the amended rules.  
To ensure availability of morphine in all palliative care centres, only those units which have a 
licence for oral morphine, will be provided for funds to set up a palliative care service (as 
described above).  
RCCs should facilitate the procurement of licences for morphine by other palliative care centers. 
This can be done by organising morphine availability workshop in all states and Union territories 
conducted by each RCC. 
 
Opioid Availability Workshops : Up to 3 workshops over the 5 year period organised by each RCC 
involving palliative care professionals and NGOs, with all concerned Departments at State and 
District levels in the State, and of the adjoining State/Union Territory where there is no RCC. This 
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task force will recruit a team of facilitators who can act as resource persons at these workshops 
and help with follow up. 
 
Coverage:  All States and Union Territories 
Timeline:  3 workshops each year for every year of FYP in every RCC 
Budget:  Rs 0.75 crores 
 
Scheme3 Opioid Availability Workshops  per 
Workshop 
per 
annum 
FYP in 
Rs 
FYP in 
Cr 
 Maximum of 3 workshops in 5 years 
@ Rs 1 lakh per workshop for 25 
RCCs 
 
Expenses including travel for 
facilitators to attend these 
workshops and to continue follow up 
100000 
 
 
 
50000 
 7500000 
 
 
 
3750000 
0.75 
 
 
 
0.375 
Scheme 3 Total   7500000 1.125 
 
Outcome Measures:  
Number of States and UTs with Simplified Narcotics Rules and simple standard operating procedures 
for their implementation 
Annual consumption of morphine 
A system of proper documentation of morphine stocks and dispensing 
 
SCHEMES 4 AND 5: EDUCATION, CURRICULUM DEVELOPMENT AND REGIONAL 
TRAINING CENTRES 
 
Development of Regional Palliative care Training Centres: 
Capacity development of five palliative care centers in five geographical regions in the country to 
empower them to develop as nodal training centers which can take on education and training of 
personnel in the region 
The role of Regional Training Centres:  
To train personnel in palliative care by conducting “hands-on” training courses of four to six 
weeks, which will be conducted for doctors, nurses and social workers by these regional centers. 
Selection of Regional Training Centres: 
To set up the Regional centers, applications will be invited from institutions interested in taking up 
this program and selection will be done in collaboration with RCCs in the region. A teaching 
module for the training programs will be developed in collaboration with NGOs in the field like 
Indian Association of Palliative Care (IAPC). 
The task force will request NGOs in the field like Indian Association of Palliative Care (IAPC) to 
set standards for training in all regional centres - by a committee that will oversee and discuss 
with the Regional training centres, ensure uniformity, help with resource persons, evaluation and 
monitoring and development of a module.  
Coverage: All States and UTs, 25 RCCs and 100 Cancer Treatment Centres 
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Timeline: Given individually in attached spreadsheet.  
Budget: Training and Sensitization provided in RCC and Out of RCC Schemes (Item 7) 
   
Scheme 4 Education & Curriculum Devpt Per 
meeting 
Total in 
lakhs 
Total in 
crores 
 12 Working Group Meetings, each 
with 6 faculty for development of 
teaching modules/Curricula for 
Palliative Care Professionals and 
Undergraduates to be done over 
3 years 
1,50,000 1800000 0.18 
 6 Standard Setting Group 
Meetings for developing tools and 
methods for Qualitative 
Assessment of Palliative Care 
Services rendered to be finished 
in 3 years 
1,50,000 900000 0.09 
Scheme 4 Total  2700000 0.27 
 
 
 
Scheme 5 5 Regional Training Centres  per 
month 
per 
annum 
FYP in RS 
As per 
time-line 
FYP in 
Crores 
 Staff     
 1 full time 
doctor+nurse+Secretary 
50000 600000   
 Office  100000   
 Course Material  200000   
 AV Aids   200000  
 Library   100000  
 Visiting Faculty Expense 4 
courses*2 faculty 
 200000   
 Total per Centre p.a.  1100000   
Scheme 5 Total for 5 Centres over 5 years 
per timeline 
  29400000 2.94 
 
 
Appendix- 4: List of currently available training centres, courses and contents 
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OUTCOME MEASURES 
Teaching modules/Curriculum for Courses in Palliative  
Tools and methods for Qualitative Assessment of Palliative Care 
Services  
 
List and Number of courses run 
Number of Doctors, Nurses, social workers and volunteers trained 
Number of Training centres accredited every year 
 
Scheme 6: PATIENT ADVOCACY & AWARENESS BY NGOS/INSTITUTIONS 
 
Awareness programs: Aimed at improved awareness among public about the possibilities of pain 
relief and palliative care to decrease suffering in the community and to improve participation of 
the community in palliative care.  
 
Peer Support Meetings 4 each year provided 
For all 25 RCCs in the Reintegration and Rehabilitation Program 
For all 100 Palliative Care Centres in the Out of RCC Scheme 
 
Palliative Care Awareness Programs 
 
Scheme 6 Patient Advocacy & Awareness 
by NGOs/Institutions 
Per 
Awareness 
Program 
per 
annum 
FYP in 
Rs 
FYP in 
Cr 
 600 Palliative Care Awareness 
Programs ~120 p.a. 
(Publicity Rs 1000+ 
Handouts/posters 
6000+Venue/AV 600+Honorarium 
for faculty Rs 400) 
8000 960000 4800000 0.48 
Scheme 6 Total   4800000 0.48 
 
Outcome Measures: 
Number of Programs conducted 
Number of Participants  
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 Annex 3: Palliative Care Policy Kerala 
 
The Palliative Care Policy for the State of Kerala 
The Government of Kerala has recently declared a palliative care policy highlighting the 
concept of community-based care and giving guidelines for the development of services with 
community participation for the incurably ill and bedridden patients. (HEALTH & FAMILY 
WELFARE (J)DEPARTMENT GO(P) No 109/2008/H&FWD Dated Thiruvanathapuram 15.4.2008). 
The new policy aims at providing palliative care to as many needy as possible in the state. 
The policy which put forth short-term as well as long-term objectives envisage the guiding 
principle of home-based care, palliative care as part of general health care and adequate 
orientation of available manpower and existing institutions in the heath care field. The 
Government has made it clear that the governmental machinery shall work in harmony with 
Community Based Organization (CBOs), Non-Governmental Organization (NGOs) which have 
acquired training in delivery of palliative care. In practical terms, the document aims at 
mobilising volunteers locally, providing them with training in palliative care, empowering 
these trained groups to work with the health care system. The Government also expects the 
local self governments to offer good support to the community volunteers in this activity.  
The action plan with the policy has the following immediate goals in the next two years 
• To train at least 300 volunteers in palliative care in each district 
• To conduct sensitisation programmes for 25% of all doctors, nurses and other 
health/social welfare workers in the state 
• At least 150 doctors and 150 nurses in the state to successfully complete the 
Foundation Course in Palliative Care 
• At least 50 more doctors and 50 more nurses in the state to successfully complete 
six weeks training in palliative care (Basic Certificate Course in Palliative Care). 
• To develop more than 100 new community-based palliative care programmes with 
home care services in the state with active participation of CBOs, LSGIs and local 
government and other health care institutions 
• To develop common bodies/platforms in at least 25% of the LSGIs to coordinate the 
activities 
• To develop at least four more training centres in the state for advanced training in 
palliative care 
• To introduce palliative care into the training programmes for elected members to 
LSGIs and concerned officials 
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 Annex 4: Letter from Human Rights Watch to the Union Ministry of 
Health and Family Welfare 
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Annex 5: Letter from Human Rights Watch to the 
Medical Council of India 
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A 55-year-old woman holds her husband, a
67-year-old lung cancer patient. He receives
palliative care and pain treatment from an
NGO in south Kerala, India. 
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Unbearable Pain 
India’s Obligation to Ensure Palliative Care
It felt as if someone was pricking me with needles. 
I just kept crying [throughout the night]. 
With that pain you think death is the only solution. 
—Priya, Hyderabad
Every year, hundreds of thousands of people in India develop severe, chronic pain due to cancer, HIV/ AIDS, and
a variety of other health conditions. Although pain treatment medications—and broader palliative care services—
are effective, safe, and relatively inexpensive, only a small fraction of those suffering severe pain has access to
them. The majority suffers unnecessarily. Many patients told Human Rights Watch that living with severe pain was
so bad they would rather die or commit suicide than live in such agony.
The World Health Organization recognizes palliative care as an integral and essential part of healthcare for cancer,
HIV, and various other health conditions. Yet, the Indian government has done little to ensure its availability to
those in need. It has failed to incorporate palliative care into anti-cancer and HIV policies in a meaningful way; to
ensure that healthcare workers receive adequate instruction in palliative care; and many states maintain
excessively strict narcotics regulations that directly impede morphine availability at hospitals and pharmacies. 
The government’s failure to take reasonable steps to improve palliative care and pain treatment availability
violates the right to health. In some cases, its failure to ensure pain treatment is available to those in need
violates the prohibition of cruel, inhuman, or degrading treatment. The Indian and state governments need to take
immediate steps to remedy this unnecessary suffering. 
